carmustine has been researched along with methotrexate in 207 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 107 (51.69) | 18.7374 |
1990's | 40 (19.32) | 18.2507 |
2000's | 32 (15.46) | 29.6817 |
2010's | 22 (10.63) | 24.3611 |
2020's | 6 (2.90) | 2.80 |
Authors | Studies |
---|---|
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Benfenati, E; Raska, I; Toropov, AA; Toropova, AP | 1 |
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
Barber, J; Dawson, S; Kenna, JG; Paul, N; Stahl, S | 1 |
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Furusawa, E; Furusawa, S; Lee, JY; Suzuki, N | 1 |
Cohen, SC; Gabelnick, HL; Goldin, A; Johnson, RK | 1 |
Kyalwazi, SK; McIntire, KR; Primack, A; Vogel, CL; Waldmann, TA | 1 |
Bruntsch, U | 1 |
Alberts, DS; Durie, BG; Hamburger, AW; Moon, TE; Salmon, SE; Soehnlen, B | 1 |
Habs, M; Schmähl, D | 1 |
Morgenthaler, FR; Pettavel, J | 1 |
Bast, RC; Borsos, T; Greene, SL; Ohanian, SH; Rapp, HJ; Segerling, M; Zbar, B | 1 |
Livingston, RB | 1 |
Vogl, SE | 1 |
Abeloff, MD; Ettinger, DS; Khouri, NF; Lenhard, RE | 1 |
Bartolucci, AA; Dorfman, RF; Durant, JR; Gams, RA | 1 |
Filler, J; Humphrey, GB; Krous, HF; Maxwell, JD; VanHoutte, JJ | 1 |
Freund, M; Ostendorf, P; Waller, HD | 1 |
Fiebig, HH; Schmähl, D | 2 |
Blasberg, RG | 1 |
Koós, R; Krauze, I; Péter, A; Schuler, D | 1 |
Bremer, AM; Cohen, M; Freeman, AI; Sinks, LF; Sumer, T; Thomas, PR | 1 |
Hartmann, D; Obrecht, JP | 1 |
Goldin, A | 1 |
Bonmassar, E; Goldin, A; Nicolin, A | 1 |
Cohen, ME; Duffner, PK; Freeman, AI; Sinks, LF; Thomas, PR | 1 |
Marsh, JC | 1 |
Levin, VA; Wilson, CB | 1 |
Bergsagel, DE | 1 |
Garfield, JS | 1 |
Burholt, DR; Hagemann, RF; Lesher, S; Schenken, LL | 1 |
Wilson, CB | 1 |
Dombernowsky, P; Nissen, NI | 1 |
Helfman, D; Zucker, RM | 1 |
Morley, AA; Trainor, KJ | 1 |
Burchenal, JH; Clarkson, BD; Cunningham, IB; Dowling, MD; Gee, TS | 1 |
Clarkson, BD; Cunningham, I; Dowling, MD; Gee, TS; Haghbin, M; Middleman, MP | 1 |
Shapiro, WR | 2 |
Posner, JB; Shapiro, WR | 1 |
Burchenal, JH; D'Angio, GJ; Exelby, PR; Lieberman, PH; Murphy, ML; Wollner, N | 1 |
Burchenal, JH; D'Angio, G; Exelby, P; Lieberman, PH; Murphy, ML; Wollner, N | 1 |
Grau, C; Overgaard, J | 1 |
Matthay, RA; Twohig, KJ | 1 |
Bessell, EM; Firth, J; Holland, I; Hope, T; Lowe, J; Punt, J | 1 |
Bastion, Y; Coiffier, B; Tigaud, JD | 1 |
Busnardo, B; Casara, D; De Besi, P; Fiorentino, MV; Girelli, ME; Nacamulli, D; Simioni, N; Toso, S; Zorat, P | 1 |
Latour, JF; Mignot, A; Ranchere, JY; Tabone, E | 1 |
Brito Barroso, ML; González Brito, G; Hernández Nieto, L; Marsá Vila, L; Raya Sánchez, JM | 1 |
Coleman, EA; Lord, J | 1 |
Furusawa, E; Furusawa, S | 1 |
Ward, MJ; White, JP | 1 |
Benoit, B; Grahovac, Z; Hugenholtz, H; Richard, M; Russell, N; Stewart, DJ | 1 |
Cha, RJ | 1 |
Abernathey, CD; Kooistra, KL; Laws, ER; Wilcox, GL | 1 |
Cagnazzo, P; Cardi, G; Ficorella, C; Frati, L; Marchei, P; Marchetti, P; Ricciuti, FP | 1 |
Cabanillas, F; Hagemeister, FB; Jagannath, S; McLaughlin, P; Redman, JR; Rodriguez, MA; Swan, F; Velasquez, WS | 1 |
Shapiro, JR; Shapiro, WR | 1 |
Ben-Sira, I; Cohen, S; Nissenkorn, I; Stark, B; Wysenbeek, YS; Zaizov, R | 1 |
Huijgens, PC; Ossenkoppele, GJ; Reijneke, RM; Thomas, LL; van der Lelie, J; Wijngaarden, MJ | 1 |
Andrien, JM; Bitar, N; Bury, J; De Witte, T; Debusscher, L; Marie, JP; Peetermans, M; Solbu, G; Stryckmans, P; Suciu, S | 1 |
Correa Alves, A; de Andrea, ML; de Camargo, B; Franco, EL; Machado, JC | 1 |
Gomis, F; Javier Rafecas, F; Lorenzo, IJ; Martín-Aragonés, G; Martínez, JA; Marty, ML; Sanz, GF; Sanz, MA; Sayas, MJ | 1 |
Goldin, A; Wittes, RE | 1 |
Anderson, CC; Cawley, JC; Goldstone, AH; Harper, PG; Jelliffe, AM; Jones, M; Linch, DC; Machin, SJ; McLennan, KA; Souhami, RL | 1 |
Blasberg, RG; Groothuis, DR | 1 |
Boyett, J; Crist, W; Doering, EJ; Hvizdala, E; Pullen, J; Ruymann, F; Steuber, CP; Sullivan, MP; Trueworthy, R | 1 |
Ozhiganov, EL; Platinskiĭ, LV; Sokolova, VD | 1 |
Cohen, IJ; Matz, S; Mor, C; Stern, S; Vogel, R; Weitz, R; Zaizov, R | 1 |
Gang, M; Kline, I; Sirica, AE; Venditti, JM; Woodman, RJ | 1 |
Heiby, JR; Jeejeebhoy, HF; Owens, AH; Sensenbrenner, LL | 1 |
Carter, SK; Comis, RL | 1 |
Jacobi, H | 1 |
Elfenbein, GJ; Owens, AH; Sensenbrenner, LL; Zawatzsky, LS | 1 |
Brugerie, E; Huong, TH; Lheritier, J; Pouillart, R | 1 |
Cheeks, JB; Laster, WR; Schabel, FM; Skipper, HE; Trader, MW | 1 |
Glidewell, O; Holland, JF | 1 |
Burchenal, JH; Clarkson, BD; Haghbin, M; Miké, V; Murphy, ML; Tan, CC | 1 |
Burchenal, JH; Clarkson, BD; Cunningham, B; Dowling, MD; Gee, TS; Haghbin, M; Tan, CT | 1 |
Lustman-Marechal, J | 1 |
Bagley, CM; Canellos, GP; Chabner, BA; De Vita, VT; Schein, PJ; Young, RC | 1 |
McElwain, TJ | 1 |
Pruzanski, W; Saito, S | 1 |
Carter, SK; Livingston, RB | 1 |
Omura, GA; Roberts, GA | 1 |
Choi, SC; Goldin, A; Straus, MJ | 1 |
Chernik, NL; Posner, JB; Shapiro, WR | 1 |
Jacquez, JA; Ullman, NS | 1 |
Fairley, GH | 1 |
Adamson, RH; Gallo, RC; Riddick, D; Waalkes, TP | 1 |
Collis, CH | 1 |
Gamsu, G; Putman, CE; Sostman, HD | 1 |
Herfarth, C; Schlag, P; Schreml, W; Vergani, G; Wolfrum, J | 1 |
Galligioni, E; Grigoletto, E; Magri, MD; Tirelli, U; Trovò, MG; Tumolo, S; Veronesi, A | 1 |
Hahn, GM; Shiu, EC | 1 |
Rubin, P | 1 |
Bier, H; Bier, J; Maurer, HR; Ohanian, S; Osman, FA; Siegel, T | 1 |
Heim, ME; Queisser, W | 1 |
deKernion, JB; Lindner, A | 1 |
Cohen, ME; Duffner, PK; Freeman, AI; Heffner, RR | 1 |
Chandler, WF; Doan, KM; Ensminger, WD; Greenberg, HS; Gyves, JW; Kindt, GW; Phillips, TW; Seeger, JF | 1 |
Carney, DN; Kinsella, TJ; Mitchell, JB | 1 |
Fukumoto, M; Kimura, I; Kitajima, K; Lai, M; Nishimura, M; Oda, Y; Takahashi, I; Yorimitsu, S | 1 |
Könyves, I; Müntzing, J; Rozencweig, M | 1 |
Benoit, Y; Bury, J; Delbeke, MJ; Fière, D; Otten, J; Solbu, G; Stryckmans, PA; Suciu, S | 1 |
Brema, F; Cinquegrana, A; De Palma, M; Nobile, MT; Porcile, G; Rosso, R; Rubagotti, A | 1 |
Albani, F; Baruzzi, A; Bollini, C; Bollini, P; Cacciari, L; Ida, N; Riva, R | 1 |
Gerner, EW; Herman, TS; Sweets, CC; White, DM | 1 |
Durie, BG; Herman, TS; Hutter, JJ | 1 |
Boyett, JM; Duncan, MH; Dyment, PG; Falletta, JM; Humphrey, GB; Land, VJ; Pullen, DJ; Starling, KA; Sullivan, MP; Vats, T | 1 |
Clarkson, BD; Gee, TS; Mertelsmann, R; Miké, V; Passe, S | 1 |
Liter, ME | 1 |
Falkson, G; Falkson, HC | 1 |
Bertram, JS; Janik, P | 1 |
Lin, HS | 1 |
Garattini, S; Libretti, A; Marsoni, S; Morasca, L; Ottolenghi, L; Piazza, E; Soresi, E | 1 |
Dufour, FD; Mah, SG; Morton, DL; Okada, GT | 1 |
Algermissen, B; Czarnetzki, BM; Kohlmus, CM; Schadendorf, D; Worm, M | 1 |
Ciaccia, D; Corey, GR; Peters, W; Thel, MC; Vredenburgh, JJ | 1 |
Chapman, CS; Ghosh, K; Murphy, P; Sivakumaran, M; Wood, JK | 1 |
Barnett, MJ; Fairey, RN; Hogge, DE; Klasa, RJ; Klingemann, HG; Nantel, SH; Reece, DE; Shepherd, JD; Sutherland, HJ; Voss, NJ | 1 |
Dommann-Scherrer, C; Honegger, HP; Jacky, E; Jost, LM; Maurer, R; Sauter, C; Stahel, RA | 1 |
Bosly, A; Coiffier, B; Gisselbrecht, C; Haioun, C; Herbrecht, R; Lepage, E; Morel, P; Reyes, F; Sebban, C; Tilly, H | 1 |
Barnett, MJ; Klingemann, HG; Nantel, SH; Phillips, GL; Reece, DE; Shepherd, JD; Spinelli, JJ; Sutherland, HJ | 1 |
Bout, M; Brémond, JL; Dayan, A; Delain, M; Domenech, J; Gihana, E; Linassier, C; Petit, A; Petitdidier, C; Truglio, D | 1 |
Zackheim, HS | 2 |
Bloch, DA; Brown, DM; Kitchell, BE; Luck, EE; Orenberg, EK; Woods, LL | 1 |
Bergeron, C; Chatel, M; Darcel, F; Edan, C; Faivre, J; Jouan, H; Le Moine, P; Le Prise-Fleury, E; Patte, C; Tass, P | 1 |
Elonen, E; Jokipii, A; Lautenschlager, I; Lyytikäinen, O; Ruutu, P; Tiittanen, L | 1 |
Bessell, EM; Firth, JL; Graus, F; Hope, DT; Lopez-Guillermo, A; Moloney, AJ; Punt, JA; Villa, S | 1 |
Calabresi, F; De Sanctis, V; Fiacchini, M; Gherlinzoni, F; Mandelli, F; Martelli, M; Martelli, MF; Meloni, G; Papa, G; Tura, S; Vignetti, M; Zinzani, PL | 1 |
Gazdar, AF; Ghosh, BC; Ihde, DC; Johnson, BE; Linnoila, RI; Minna, JD; Mulshine, JL; Oie, HK; Pass, HI; Phelps, R; Russell, EK; Shaw, GL; Steinberg, SM | 1 |
Haynes, AP; Iqbal, A; McQuaker, IG; Russell, NH | 1 |
Purdy, MH | 1 |
Behringer, D; Fetscher, S; Finke, J; Kanz, L; Lange, W; Lübbert, M; Mertelsmann, R | 1 |
Barbui, T; Bertini, M; Botto, B; Cinieri, S; Cortellazzo, S; Falda, M; Freilone, R; Grignani, F; Levis, A; Liberati, AM; Locatelli, F; Lovisone, E; Marmont, F; Pizzuti, M; Resegotti, L; Rossi, A; Viero, P; Vitolo, U | 1 |
Baccarani, M; Barillari, G; Cerno, M; Damiani, D; Fanin, R; Geromin, A; Infanti, L; Rinaldi, C; Savignano, C; Silvestri, F; Zaja, F | 1 |
Capria, S; Mandelli, F; Meloni, G; Modena, V; Vignetti, M | 1 |
Barbui, T; Bellavita, P; Cortelazzo, S; Marchioli, R; Marfisi, RM; Rambaldi, A; Rossi, A; Viero, P | 1 |
Cheng, AL; Hung, RL; Liu, MY; Uen, WC; Wang, CH; Yeh, KH | 1 |
Damian, MS; Leweke, F; Schachenmayr, W; Schindler, C | 1 |
Buckner, JC; Lewis, JE; McElroy, EA | 1 |
Aurlien, E; Holte, H; Jakobsen, E; Kvalheim, G; Kvaløy, S; Pharo, A; Smeland, EB | 1 |
Dreger, P; Glass, B; Kuse, R; Löffler, H; Schmitz, N; Schoch, R; Sonnen, R; Uharek, L; von Neuhoff, N | 1 |
Korfel, A; Thiel, E | 1 |
Berry, D; Cavanaugh, C; Fehdrau, R; Gilbert, CJ; Hussein, A; McKinstry, C; Peters, WP; Petros, WP; Ross, M; Rubin, P; Vredenburgh, J | 1 |
Korfel, A; Krackhardt, A; Schwartz, S; Thiel, E | 1 |
Byrne, JL; Carter, GI; Cull, GM; Hale, G; Haynes, AP; Miflin, G; Rebello, P; Russell, NH; Waldmann, H | 1 |
Bosly, A; Brice, P; Brière, J; Coiffier, B; Gaulard, P; Gisselbrecht, C; Haioun, C; Lederlin, P; Lepage, E; Morel, P; Nouvel, C; Reyes, F; Salles, G; Sebban, C; Tilly, H | 1 |
Bertz, H; Engelhardt, M; Finke, J; Hahn, J; Holler, E; Kunzmann, R; Reisser, S; Veelken, H; Wäsch, R | 1 |
Carella, AM; Cavaliere, M; Corsetti, MT; De Stefano, F; Ferrara, R; Lambelet, P; Lerma, E; Loni, C; Pinotti, G; Romanelli, A; Tedeschi, L; Valbonesi, M; Verdiani, S; Vinci, M | 1 |
Weiss, M | 1 |
Bessell, EM; Byrne, P; Graus, F; Holland, I; López-Guillermo, A; Petit, J; Verger, E; Villá, S | 1 |
Bernard, M; Casassus, P; Delain, M; Desablens, B; Guilhot, F; Hunault-Berger, M; Ifrah, N; Jouet, JP; Milpied, N; Sadoun, A | 1 |
Bessell, EM; Byrne, P; Graus, F; López-Guillermo, A; Montserrat, E; Nomdedeu, B; Petit, J; Verger, E; Villá, S | 1 |
Ariatti, C; Bertini, M; Boccomini, C; Botto, B; Calvi, R; Capello, D; Carbone, A; Freilone, R; Gaidano, G; Gallo, E; Gloghini, A; Milan, I; Novero, D; Orsucci, L; Palestro, G; Parvis, G; Pregno, P; Saglio, G; Vitolo, U; Vivenza, D; Zagonel, V | 1 |
Clemente González, C; García Parés, D; García-Bragado Dalmau, F; Guardia Sánchez, R; Pérez Ayuso, MJ; Porcar Ramells, C | 1 |
Bataille, R; Harousseau, JL; Mahé, B; Milpied, N; Misbahi, R; Moreau, P; Morineau, N; Rapp, MJ; Vigier, M | 1 |
Aynehchi, S; Choudhury, MS; Drinis, S; Finkelstein, MP; Konno, S; Samadi, AA; Tazaki, H | 1 |
Arellano-Rodrigo, E; Bessell, EM; Graus, F; López-Guillermo, A; Montserrat, E; Nomdedeu, B | 1 |
Mead, G; Woodcock, J; Young, C | 1 |
DIXON, GJ; SCHABEL, FM; SELLERS, SM; SIDWELL, RW | 1 |
Fickers, M; Haaxma-Reiche, H; Hansen, M; Kluin-Nelemans, HC; Poortmans, PM; Rozewicz, C; Soubeyran, P; Taphoorn, M; Teodorovic, I; Thomas, J; Van den Bent, M; van Glabbeke, M; Van Imhoff, G; Van't Veer, M | 1 |
Abrey, LE; Anderson, ND; Caron, D; Correa, DD; Crump, M; DeAngelis, LM; Forsyth, P; Mason, WP; Moskowitz, CH; Nimer, SD; Paleologos, N; Stewart, D; Zelenetz, A | 1 |
Bromberg, JE; Haaxma-Reiche, H; Harder, H; Holtel, H; Kluin-Nelemans, HC; Menten, J; Poortmans, P; van den Bent, MJ | 1 |
Bessell, EM; Graus, F; Lewis, SA; Lopez-Guillermo, A; Petit, J; Verger, E; Villa, S | 1 |
Arbion, F; Autret, A; Benboubker, L; Bonnaud, I; Cottier, JP; de Toffol, B; Debiais, S; Destrieux, C; Saudeau, D | 1 |
Berdel, WE; Diehl, V; Dörken, B; Engert, A; Glossmann, JP; Hossfeld, DK; Josting, A; Kirchner, HH; Kisro, J; Mapara, M; Metzner, B; Rudolph, C; Sieber, M; Sienawski, M; Sieniawski, M | 1 |
Birkmann, J; Brücher, J; Fischer, L; Hossfeld, DK; Jahnke, K; Kirchen, H; Korfel, A; Martus, P; Nowrousian, MR; Pasold, R; Peschel, C; Stelljes, M; Thiel, E | 1 |
Alterini, R; Bernardi, F; Bosi, A; Carrai, V; Longo, G; Nassi, L; Rigacci, L | 1 |
Rao, PS | 1 |
Ayanoglu, E; Baumhueter, S; Bostian, KA; Brady, L; Breckenridge, N; Browne, LJ; Calvin, JT; Day, GJ; Dunlea, S; Eynon, BP; Ferng, J; Fielden, MR; Fujimoto, SY; Furness, LM; Ganter, B; Gong, L; Hu, C; Idury, R; Jarnagin, K; Judo, MS; Kolaja, KL; Lee, MD; McSorley, C; Minor, JM; Nair, RV; Natsoulis, G; Nguyen, P; Nicholson, SM; Pearson, CI; Pham, H; Roter, AH; Sun, D; Tan, S; Thode, S; Tolley, AM; Tugendreich, S; Vladimirova, A; Yang, J; Zhou, Z | 1 |
Derigs, G; Feuerhake, F; Finke, J; Frickhofen, N; Guttenberger, R; Ihorst, G; Illerhaus, G; Marks, R; Ostertag, C; Volk, B | 1 |
Bay, JO; Berthou, C; Bertrand, P; Brion, A; Camilleri-Broët, S; Colombat, P; Delepine, R; Delwail, V; Desablens, B; Lamy, T; Lemevel, A; Linassier, C; Rachieru, P | 1 |
Bishton, MJ; Haynes, AP | 1 |
Deray, G; Isnard-Bagnis, C; Janus, N; Karie, S; Launay-Vacher, V | 1 |
Danø, K | 1 |
About, M; Gerlotto-Borne, MC; Jacot, W; Pouderoux, S; Poujol, S; Romieu, G; Thezenas, S | 1 |
Ballman, KV; Brown, PD; Carrero, XW; Colgan, JP; Fitch, TR; Gilbert, MR; Habermann, TM; Hawkins, RB; Kurtin, PJ; Laack, NN; Morton, RF; O'Fallon, JR; O'Neill, BP; Pajon, ER; Scheithauer, BW; Windschitl, HE | 1 |
Angelopoulou, MK; Beris, P; Constantinou, N; Dervenoulas, J; Diamantopoulos, P; Dimopoulos, MA; Dimou, M; Economopoulou, C; Economopoulou, P; Efthimiou, A; Georgiou, G; Kalpadakis, C; Katsigiannis, A; Korkolopoulou, P; Kotsianidis, I; Kyrtsonis, MC; Levidou, G; Meletis, J; Panayiotidis, P; Pangalis, GA; Papageorgiou, SG; Pappa, V; Tsirigotis, P; Vassilakopoulos, TP | 1 |
Cheng, AL; Huang, HC; Kuo, SH; Lin, CW | 1 |
Boyce, TG; Burnette, BL; Jentoft, MA; Porrata, LF; Witzig, TE | 1 |
Ancochea, Á; Fernández-Rodriguez, C; García-Pallarols, F; Gimeno, E; Salar, A; Sánchez-González, B | 1 |
Agis, H; Berghoff, AS; Bojic, M; Kalhs, P; Preusser, M; Rabitsch, W; Sperr, WR; Troch, M; Widhalm, G; Wöhrer, A | 1 |
Acebo-Mariñas, E; Aperribay-Esparza, A; de Quintana-Sancho, A; Gardeazabal-García, J | 1 |
Bentz, M; Binder, M; Deckert, M; Edinger, M; Egerer, G; Finke, J; Fricker, H; Frickhofen, N; Fritsch, K; Hader, C; Hau, P; Hirt, C; Ihorst, G; Illerhaus, G; Kasenda, B; Keller, U; Lamprecht, M; Möhle, R; Pfreundschuh, M; Röth, A; Schorb, E; Stilgenbauer, S; Valk, E; von Baumgarten, L; Wolf, HH | 1 |
Eaton, P; Rudyk, O | 1 |
Baars, JW; Brouwer, R; Chamuleau, MED; de Jong, D; de Wreede, LC; Demandt, AMP; Doorduijn, JK; Hardi, L; Kersten, MJ; Kluin, PM; Nijland, M; Oosten, LEM; Siemes, C; Smeekes, OS; Stevens, WBC; Thielen, FW; Uyl-de Groot, CA; van Imhoff, GW; Veelken, H | 1 |
Wang, CH; Zhan, W | 1 |
Bettarello, G; Costa, LJM; da Matta Abreu, M; Dos Santos, KB; Hallack Neto, AE; Mayrink, GTC; Mota, MA; Pereira, J; Ribeiro, LC | 1 |
Arcari, A; Centurioni, R; Evangelista, A; Freilone, R; Ladetto, M; Liberati, AM; Luminari, S; Massidda, S; Merli, F; Musuraca, G; Nassi, L; Patti, C; Pavone, V; Peli, A; Pulsoni, A; Re, A; Salvi, F; Spina, M; Stelitano, C; Tani, M; Tucci, A; Volpetti, S; Zanni, M | 1 |
Dini, D; Rodriguez Y Baena, F; Zhan, W | 1 |
Zhan, W | 1 |
Alañá, M; Barbero-Bordallo, N; Barceló, MI; Barón, M; Bobillo, S; Bruna, J; Caballero, AC; Cacabelos, P; Caldú Agud, R; Camro, I; Dlouhy, I; Encuentra, M; Erro, ME; Estela, J; Gállego Pérez-Larraya, J; García Molina, E; García-Catalán, G; Gómez-Vicente, L; Graus, F; Huertas, N; Ibáñez-Juliá, MJ; Lado, T; Martínez, P; Mercadal, S; Muntañola, A; Salar, A; Sancho, JM; Solé-Rodríguez, M; Velasco, R; Vidal, N | 1 |
Duell, J; Einsele, H; Gerhard-Hartmann, E; Heidemeier, A; Krummenast, FC; Rosenwald, A; Steinhardt, MJ; Topp, MS | 1 |
Adlington, J; Auer, D; Bessell, EM; Bishton, MJ; Byrne, P; Figueroa, R; Fox, CP; Grainge, MJ; James, E; Kaji, FA; Martinez-Calle, N; O'Donoghue, M; Paine, S; Smith, S; Sovani, V | 1 |
Grommes, C; Modelevsky, L; Reiss, SN; Yerram, P | 1 |
Nilius-Eliliwi, V; Schroers, R; Seidel, S; Treiber, H; Vangala, DB | 1 |
34 review(s) available for carmustine and methotrexate
Article | Year |
---|---|
Treatment of overt CNS leukemia.
Topics: Adrenal Cortex Hormones; Aminopterin; Antineoplastic Agents; Asparaginase; Blood-Brain Barrier; Carmustine; Child; Cytarabine; Drug Therapy, Combination; Humans; Injections, Spinal; Leukemia; Meningeal Neoplasms; Methotrexate; Pyrimethamine | 1979 |
The effects of cancer chemotherapeutic agents on normal hematopoietic precursor cells: a review.
Topics: Alkylating Agents; Animals; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Asparaginase; Benzamides; Busulfan; Carmustine; Cisplatin; Cyclophosphamide; Cytarabine; Drug Evaluation, Preclinical; Erythrocytes; Fluorouracil; Hematopoietic Stem Cells; Humans; Hydroxyurea; Lomustine; Methotrexate; Nitrogen Mustard Compounds; Spleen; Vinca Alkaloids | 1976 |
Chemotherapy: the agents in current use.
Topics: Antineoplastic Agents; Brain Neoplasms; Carmustine; Dacarbazine; Drug Therapy, Combination; Glioma; Humans; Lomustine; Medulloblastoma; Methotrexate; Nitrogen Mustard Compounds; Procarbazine; Semustine; Teniposide; Vincristine | 1975 |
The treatment of plasma cell myeloma.
Topics: Animals; Carmustine; Cytarabine; Doxorubicin; Drug Evaluation, Preclinical; Fluorouracil; Humans; Melphalan; Methotrexate; Mice; Mice, Inbred BALB C; Multiple Myeloma; Myeloma Proteins; Prednisone; Procarbazine; Remission, Spontaneous | 1976 |
Pulmonary effects of cytotoxic agents other than bleomycin.
Topics: Antineoplastic Agents; Bleomycin; Busulfan; Carmustine; Cyclophosphamide; Humans; Lomustine; Methotrexate; Mitomycins; Pulmonary Fibrosis; Vinblastine; Vindesine | 1990 |
[Treatment of relapses and failures in disseminated Hodgkin's disease].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Carmustine; Cisplatin; Cyclophosphamide; Cytarabine; Dacarbazine; Doxorubicin; Epirubicin; Etoposide; Hodgkin Disease; Humans; Ifosfamide; Mechlorethamine; Melphalan; Methotrexate; Mitoguazone; Prednisone; Procarbazine; Remission Induction; Transplantation, Autologous; Transplantation, Homologous; Vinblastine; Vincristine | 1991 |
Chemotherapy for glioblastoma multiforme.
Topics: Antineoplastic Agents; Brain Neoplasms; Carmustine; Cisplatin; Fluorouracil; Humans; Methotrexate; Nursing Assessment | 1991 |
Drug-induced adverse pulmonary reactions.
Topics: Amiodarone; Asthma; Bleomycin; Carmustine; Drug-Related Side Effects and Adverse Reactions; Gold; Humans; Hydrochlorothiazide; Hypertension, Pulmonary; Lung Diseases; Lupus Erythematosus, Systemic; Lymphatic Diseases; Mediastinum; Methotrexate; Nitrofurantoin; Penicillamine; Pleural Effusion; Pulmonary Edema; Pulmonary Eosinophilia; Pulmonary Fibrosis; Ritodrine | 1985 |
Principles of brain tumor chemotherapy.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Blood-Brain Barrier; Brain Neoplasms; Carbon Radioisotopes; Carmustine; Cell Line; Cisplatin; Dose-Response Relationship, Drug; Drug Resistance; Fluorouracil; Glioma; Humans; Hydroxyurea; Infusions, Intra-Arterial; Karyotyping; Kinetics; Mannitol; Methotrexate; Podophyllotoxin; Procarbazine; Rats; Tumor Stem Cell Assay | 1986 |
Unresolved issues in combination chemotherapy.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Carmustine; Cell Cycle; Cyclophosphamide; Dacarbazine; Drug Evaluation; Drug Evaluation, Preclinical; Drug Resistance; Drug Synergism; Fluorouracil; Humans; Leukemia, Experimental; Metabolic Clearance Rate; Methotrexate; Neoplasm Transplantation | 1986 |
Chemotherapy of brain tumors: physiological and pharmacokinetic considerations.
Topics: Antineoplastic Agents; Autoradiography; Biological Transport; Blood-Brain Barrier; Brain Neoplasms; Capillary Permeability; Carmustine; Fluorouracil; Humans; Kinetics; Methotrexate; Tomography, Emission-Computed; Tomography, X-Ray Computed | 1986 |
[Chemotherapy of cancer of the large intestine].
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Colonic Neoplasms; Drug Evaluation; Fluorouracil; Humans; Lomustine; Melphalan; Methotrexate; Rectal Neoplasms; Semustine; Vincristine | 1985 |
A review of chemotherapy in gastric cancer.
Topics: Adenocarcinoma; Antineoplastic Agents; Carmustine; Chlorambucil; Chromomycins; Cyclophosphamide; Cytarabine; Drug Evaluation; Drug Therapy, Combination; Floxuridine; Fluorouracil; Humans; Mechlorethamine; Methotrexate; Mitomycins; Nitrosourea Compounds; Olivomycins; Stomach Neoplasms | 1974 |
[Chemotherapy of brain neoplasms in children].
Topics: Age Factors; Astrocytoma; Blood-Brain Barrier; Brain Neoplasms; Carmustine; Child; Cyclophosphamide; Drug Therapy, Combination; Ependymoma; Glioblastoma; Glioma; Humans; Medulloblastoma; Methotrexate; Nitrosourea Compounds; Prognosis; Radiotherapy Dosage; Time Factors; Vincristine | 1974 |
Proceedings: Malignant lymphoma: treatment with combination chemotherapy.
Topics: Adolescent; Adult; Aged; Alkylating Agents; Antineoplastic Agents; Carmustine; Cyclophosphamide; Drug Therapy, Combination; Female; Follow-Up Studies; Hodgkin Disease; Humans; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisone; Procarbazine; Remission, Spontaneous; Vinca Alkaloids; Vincristine | 1972 |
Chemotherapy in colorectal cancer.
Topics: Carmustine; Chlorambucil; Colonic Neoplasms; Cyclophosphamide; Drug Therapy, Combination; Fluorouracil; Humans; Methotrexate; Nitrogen Mustard Compounds; Rectal Neoplasms; Vincristine | 1973 |
Single-agent therapy for Hodgkin's disease.
Topics: Alkylating Agents; Antibiotics, Antineoplastic; Antimetabolites; Antineoplastic Agents; Carmustine; Chlorambucil; Cyclophosphamide; Dactinomycin; Evaluation Studies as Topic; Fluorouracil; Hodgkin Disease; Humans; Mechlorethamine; Mercaptopurine; Methotrexate; Prednisone; Procarbazine; Thiotepa; Vinblastine; Vincristine | 1973 |
Combination chemotherapy in malignant diseases.
Topics: Adult; Antineoplastic Agents; Asparaginase; Carmustine; Child; Cyclophosphamide; Cytarabine; Cytosine; Daunorubicin; Drug Therapy, Combination; Hodgkin Disease; Humans; Immunotherapy; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Lymphoma; Male; Mechlorethamine; Mercaptopurine; Methotrexate; Nitrogen Mustard Compounds; Prednisolone; Prednisone; Procarbazine; Remission, Spontaneous; Vincristine | 1971 |
Lung damage from cytotoxic drugs.
Topics: Antineoplastic Agents; Azathioprine; Bleomycin; Busulfan; Carmustine; Chlorambucil; Cyclophosphamide; Drug Therapy, Combination; Humans; Lung; Melphalan; Mercaptopurine; Methotrexate; Mitomycins; Oxygen Inhalation Therapy; Pneumonia; Procarbazine; Radiation Injuries | 1980 |
Review: diagnosis of chemotherapy lung.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Agents; Bleomycin; Busulfan; Carmustine; Cyclophosphamide; Female; Humans; Lomustine; Lung Diseases; Lung Neoplasms; Male; Mercaptopurine; Methotrexate; Middle Aged; Pulmonary Fibrosis; Radiography | 1981 |
The Franz Buschke lecture: late effects of chemotherapy and radiation therapy: a new hypothesis.
Topics: Antineoplastic Agents; Bleomycin; Bone Marrow Diseases; Brain Diseases; Cardiomyopathies; Carmustine; Cisplatin; Doxorubicin; Gastrointestinal Diseases; Humans; Kidney Diseases; Liver Diseases; Lung Diseases; Methotrexate; Neoplasms; Radiotherapy | 1984 |
Chemotherapy in alimentary tract malignomas.
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Carmustine; Colonic Neoplasms; Cytarabine; Doxorubicin; Drug Therapy, Combination; Female; Fluorouracil; Humans; Lomustine; Male; Methotrexate; Mitomycin; Mitomycins; Rectal Neoplasms; Semustine; Stomach Neoplasms; Streptozocin; Tegafur; Vincristine | 1981 |
Chemotherapy of hormonally unresponsive prostatic carcinoma.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Carmustine; Cisplatin; Clinical Trials as Topic; Cyclophosphamide; Diethylstilbestrol; Doxorubicin; Estramustine; Fluorouracil; Humans; Imidazoles; Lomustine; Male; Methotrexate; Mitomycin; Mitomycins; Prednimustine; Prednisone; Procarbazine; Prostatic Neoplasms; Random Allocation; Streptozocin; Vincristine | 1984 |
Chemotherapy principles in the treatment of prostatic cancer.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Castration; Cisplatin; Cyclophosphamide; Doxorubicin; Drug Evaluation, Preclinical; Estradiol Congeners; Fluorouracil; Humans; Male; Methotrexate; Prostatic Neoplasms; Rats; Structure-Activity Relationship; Testosterone Congeners | 1984 |
Endocrine and cytostatic treatment of experimental mammary cancer.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Antineoplastic Agents; Carmustine; Castration; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Ergolines; Female; Fluorouracil; Mammary Neoplasms, Experimental; Methotrexate; Methylnitrosourea; Mice; Nitrosourea Compounds; Prednisolone; Rats; Tamoxifen; Vincristine | 1980 |
Regimen-related acute toxicities: pathophysiology, risk factors, clinical evaluation and preventive strategies.
Topics: Acute Disease; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Busulfan; Carboplatin; Carmustine; Clinical Trials, Phase I as Topic; Combined Modality Therapy; Cyclophosphamide; Cystitis; Female; Hepatic Veno-Occlusive Disease; Humans; Incidence; Leukemia, Myeloid; Liver; Lung Diseases, Interstitial; Lymphoma; Male; Methotrexate; Retrospective Studies; Risk Factors; Whole-Body Irradiation | 1994 |
Treatment of cutaneous T-cell lymphoma.
Topics: Carmustine; Combined Modality Therapy; Humans; Interferon-alpha; Lymphoma, T-Cell, Cutaneous; Mechlorethamine; Methotrexate; Prognosis; PUVA Therapy; Skin Neoplasms | 1994 |
Cerebral non-Hodgkin's lymphoma discovered when treating Hodgkin's disease.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Brain Neoplasms; Carmustine; Cyclophosphamide; Doxorubicin; Hodgkin Disease; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Male; Methotrexate; Neoplasms, Second Primary; Prednisone; Procarbazine; Tomography, X-Ray Computed; Vincristine | 1993 |
Chemotherapy for advanced esthesioneuroblastoma: the Mayo Clinic experience.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carmustine; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Doxorubicin; Esthesioneuroblastoma, Olfactory; Etoposide; Fatal Outcome; Female; Humans; Ifosfamide; Lymphatic Metastasis; Male; Mesna; Methotrexate; Middle Aged; Mitomycin; Nasal Cavity; Nose Neoplasms; Paranasal Sinus Neoplasms; Remission Induction; Retrospective Studies; Survival Analysis; Treatment Outcome; Vincristine | 1998 |
Cutaneous T cell lymphoma: update of treatment.
Topics: Administration, Topical; Adrenal Cortex Hormones; Antineoplastic Agents, Alkylating; Beta Particles; Carmustine; Humans; Interferon-alpha; Lymphoma, T-Cell, Cutaneous; Mechlorethamine; Methotrexate; PUVA Therapy; Retinoids; Skin Neoplasms; Treatment Outcome; Ultraviolet Rays | 1999 |
Induction therapy of adult acute lymphocytic leukemia without the use of vincristine or prednisone.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Controlled Clinical Trials as Topic; Cyclophosphamide; Cytarabine; Dactinomycin; Doxorubicin; Etoposide; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Humans; Male; Mercaptopurine; Methotrexate; Middle Aged; Mitoxantrone; Multicenter Studies as Topic; Neutropenia; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Prospective Studies; Randomized Controlled Trials as Topic; Recombinant Proteins; Remission Induction; Survival Analysis; Treatment Outcome; Vincristine | 2001 |
[Primary cardiac lymphoma: cytological diagnosis and treatment with response to polychemotherapy and hematopoietic precursor autotransplant. Presentation of a case a review of the literature].
Topics: Antineoplastic Combined Chemotherapy Protocols; Atrial Flutter; Carmustine; Cyclophosphamide; Cytarabine; Doxorubicin; Echocardiography, Transesophageal; Etoposide; Heart Failure; Heart Neoplasms; Heart Septum; Hematopoietic Stem Cell Transplantation; Humans; Hydrocortisone; Immunocompetence; Injections, Spinal; Lymphoma, Large B-Cell, Diffuse; Magnetic Resonance Imaging; Male; Melphalan; Methotrexate; Middle Aged; Pleural Effusion; Prednisone; Remission Induction; Tomography, X-Ray Computed; Transplantation Conditioning; Transplantation, Autologous; Vincristine | 2002 |
Non-hodgkins lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carmustine; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Etoposide; Humans; Idarubicin; Ifosfamide; Leucovorin; Lymphoma, Non-Hodgkin; Methotrexate; Prednisolone; Prednisone; Vincristine | 2003 |
Haematopoietic stem cell transplantation for treatment of primary CNS lymphoma: single-centre experience and literature review.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Central Nervous System Neoplasms; Female; Hematopoietic Stem Cell Transplantation; Humans; Induction Chemotherapy; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Retrospective Studies; Thiotepa; Transplantation, Autologous | 2015 |
32 trial(s) available for carmustine and methotrexate
Article | Year |
---|---|
Nitrosourea combinations in lung cancer.
Topics: Adenocarcinoma; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Carmustine; Clinical Trials as Topic; Cyclophosphamide; Drug Evaluation; Drug Therapy, Combination; Humans; Lomustine; Lung Neoplasms; Methotrexate; Nitrosourea Compounds; Semustine | 1976 |
BCNU with and without cyclophosphamide, vincristine, and prednisone (COP) and cycle-active therapy in non-Hodgkin's lymphoma.
Topics: Carmustine; Cell Cycle; Clinical Trials as Topic; Cyclophosphamide; Cytarabine; Drug Therapy, Combination; Humans; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Methotrexate; Prednisone; Prognosis; Remission, Spontaneous; Thioguanine; Time Factors; Vincristine | 1977 |
Pediatric Oncology Group experience with modified LSA2-L2 therapy in 107 children with non-Hodgkin's lymphoma (Burkitt's lymphoma excluded).
Topics: Adolescent; Antineoplastic Agents; Asparaginase; Bone Marrow; Carmustine; Child; Child, Preschool; Clinical Trials as Topic; Cyclophosphamide; Cytarabine; Daunorubicin; Female; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Male; Mediastinal Neoplasms; Meningeal Neoplasms; Methotrexate; Neoplasm Staging; Prednisone; Prognosis; Radiotherapy Dosage; Thioguanine; Vincristine | 1985 |
Chemotherapy of acute lymphocytic leukemia of childhood.
Topics: Adolescent; Adult; Antineoplastic Agents; Asparaginase; Carmustine; Cell Division; Cell Transformation, Neoplastic; Child; Child, Preschool; Daunorubicin; Humans; Infant; Infant, Newborn; Leukemia, Lymphoid; Mercaptopurine; Methotrexate; Mitosis; Prednisone; Remission, Spontaneous; Vincristine | 1972 |
Chemotherapy of hormonally unresponsive prostatic carcinoma.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Carmustine; Cisplatin; Clinical Trials as Topic; Cyclophosphamide; Diethylstilbestrol; Doxorubicin; Estramustine; Fluorouracil; Humans; Imidazoles; Lomustine; Male; Methotrexate; Mitomycin; Mitomycins; Prednimustine; Prednisone; Procarbazine; Prostatic Neoplasms; Random Allocation; Streptozocin; Vincristine | 1984 |
Comparison of chemotherapy with immunotherapy for maintenance of acute lymphoblastic leukemia in children and adults.
Topics: Adolescent; Adult; Asparaginase; BCG Vaccine; Carmustine; Child; Child, Preschool; Cyclophosphamide; Humans; Immunotherapy; Infant; Injections, Spinal; Leukemia, Lymphoid; Lymphocyte Transfusion; Mercaptopurine; Methotrexate; Middle Aged; Prednisone; Vincristine | 1983 |
Randomized trial of chemoimmunotherapy in advanced non-oat-cell lung cancer.
Topics: Adenocarcinoma; Adult; Aged; BCG Vaccine; Carcinoma, Squamous Cell; Carmustine; Clinical Trials as Topic; Cyclophosphamide; Drug Therapy, Combination; Humans; Lung Neoplasms; Male; Methotrexate; Middle Aged; Neoplasm Staging | 1982 |
Modified LSA2-L2 treatment in 53 children with E-rosette-positive T-cell leukemia: results and prognostic factors (a Pediatric Oncology Group Study).
Topics: Adolescent; Allopurinol; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Carmustine; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Daunorubicin; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Injections, Spinal; Leukemia, Lymphoid; Male; Methotrexate; Prednisone; Prognosis; Rosette Formation; T-Lymphocytes; Thioguanine; Vincristine | 1982 |
High-dose cyclophosphamide, carmustine (BCNU), and etoposide (VP16-213) with or without cisplatin (CBV +/- P) and autologous transplantation for patients with Hodgkin's disease who fail to enter a complete remission after combination chemotherapy.
Topics: Actuarial Analysis; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Diseases; Bone Marrow Transplantation; Carmustine; Cisplatin; Cyclophosphamide; Dacarbazine; Disease-Free Survival; Doxorubicin; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Leucovorin; Male; Mechlorethamine; Methotrexate; Prednisolone; Prednisone; Procarbazine; Remission Induction; Salvage Therapy; Survival Analysis; Treatment Outcome; Vinblastine; Vincristine | 1995 |
Short-term weekly chemotherapy followed by high-dose therapy with autologous bone marrow transplantation for lymphoblastic and Burkitt's lymphomas in adult patients.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Burkitt Lymphoma; Carmustine; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Leucovorin; Male; Methotrexate; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Remission Induction; Survival Rate; Transplantation, Autologous; Vincristine | 1995 |
Prognostic significance of received relative dose intensity in non-Hodgkin's lymphoma patients: application to LNH-87 protocol. The GELA. (Groupe d'Etude des Lymphomes de l'Adulte).
Topics: Adult; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Carmustine; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; France; Humans; Lymphoma, Non-Hodgkin; Methotrexate; Methylprednisolone; Middle Aged; Mitoxantrone; Prednisolone; Prognosis; Remission Induction; Survival Rate; Transplantation, Autologous; Vindesine | 1993 |
Primary non-Hodgkin's lymphoma of the CNS treated with BVAM or CHOD/BVAM chemotherapy before radiotherapy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brain Neoplasms; Carmustine; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Female; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Recurrence; Survival Rate; Vincristine | 1996 |
High-dose chemotherapy followed by autologous bone marrow transplantation versus dexamethasone, cisplatin, and cytarabine in aggressive non-Hodgkin's lymphoma with partial response to front-line chemotherapy: a prospective randomized italian multicenter s
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Carmustine; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Etoposide; Female; Fluorouracil; Humans; Leucovorin; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisone; Prospective Studies; Salvage Therapy; Vincristine | 1996 |
Correlation of in vitro drug sensitivity testing results with response to chemotherapy and survival: comparison of non-small cell lung cancer and small cell lung cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Carmustine; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Etoposide; Evaluation Studies as Topic; Humans; Lomustine; Lung Neoplasms; Mechlorethamine; Methotrexate; Palliative Care; Predictive Value of Tests; Prospective Studies; Specimen Handling; Survival Analysis; Treatment Outcome; Tumor Cells, Cultured; Vincristine | 1996 |
Early stem cell transplantation for chronic lymphocytic leukaemia: a chance for cure?
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Chlorambucil; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dexamethasone; Dose-Response Relationship, Drug; Doxorubicin; Etoposide; Female; Fluorouracil; Follow-Up Studies; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Humans; Hydrocortisone; Leukemia, Lymphocytic, Chronic, B-Cell; Male; Melphalan; Methotrexate; Methylprednisolone; Middle Aged; Mitomycins; Prednisone; Prospective Studies; Treatment Outcome; Vincristine | 1998 |
Pharmacokinetic interaction between ondansetron and cyclophosphamide during high-dose chemotherapy for breast cancer.
Topics: Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carmustine; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Dose-Response Relationship, Drug; Doxorubicin; Drug Interactions; Fluorouracil; Hematopoietic Stem Cell Transplantation; Humans; Methotrexate; Ondansetron; Prospective Studies; Transplantation Conditioning | 1998 |
Survival benefit of high-dose therapy in poor-risk aggressive non-Hodgkin's lymphoma: final analysis of the prospective LNH87-2 protocol--a groupe d'Etude des lymphomes de l'Adulte study.
Topics: Adult; Age Factors; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Carmustine; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Etoposide; Female; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Methylprednisolone; Prognosis; Prospective Studies; Remission Induction; Risk Factors; Statistics, Nonparametric; Vindesine | 2000 |
Rapid achievement of complete donor chimerism and low regimen-related toxicity after reduced conditioning with fludarabine, carmustine, melphalan and allogeneic transplantation.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cyclosporine; Female; Follow-Up Studies; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Leukapheresis; Male; Melphalan; Methotrexate; Middle Aged; Neoplasms; Prospective Studies; Survival Analysis; T-Lymphocytes; Transplantation Chimera; Transplantation Conditioning; Transplantation Tolerance; Vidarabine | 2000 |
Autografting followed by nonmyeloablative immunosuppressive chemotherapy and allogeneic peripheral-blood hematopoietic stem-cell transplantation as treatment of resistant Hodgkin's disease and non-Hodgkin's lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cyclophosphamide; Cyclosporine; Cytarabine; Etoposide; Female; Graft vs Tumor Effect; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Immunosuppressive Agents; Lymphoma, Non-Hodgkin; Male; Melphalan; Methotrexate; Middle Aged; Pilot Projects; Risk Factors; Survival Rate; Transplantation Chimera; Vidarabine | 2000 |
CHOD/BVAM regimen plus radiotherapy in patients with primary CNS non-Hodgkin's lymphoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Central Nervous System Neoplasms; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Female; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Survival Rate; Vincristine | 2001 |
Daunorubicin continuous infusion induces more toxicity than bolus infusion in acute lymphoblastic leukemia induction regimen: a randomized study.
Topics: Adolescent; Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow Transplantation; Carmustine; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Daunorubicin; Etoposide; Female; Gram-Negative Bacterial Infections; Humans; Immunocompromised Host; Infusions, Intravenous; Injections, Intravenous; Life Tables; Male; Methotrexate; Middle Aged; Neutropenia; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Remission Induction; Survival Analysis; Thrombocytopenia; Treatment Outcome; Vincristine | 2001 |
Importance of radiotherapy in the outcome of patients with primary CNS lymphoma: an analysis of the CHOD/BVAM regimen followed by two different radiotherapy treatments.
Topics: Actuarial Analysis; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Central Nervous System Diseases; Central Nervous System Neoplasms; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Female; Humans; Lymphoma; Male; Methotrexate; Middle Aged; Radiotherapy Dosage; Spain; Survival Rate; United Kingdom; Vincristine | 2002 |
High-dose methotrexate-based chemotherapy followed by consolidating radiotherapy in non-AIDS-related primary central nervous system lymphoma: European Organization for Research and Treatment of Cancer Lymphoma Group Phase II Trial 20962.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Central Nervous System Neoplasms; Combined Modality Therapy; Female; Humans; Lymphoma; Male; Methotrexate; Methylprednisolone; Middle Aged; Prospective Studies; Survival Analysis; Teniposide; Treatment Outcome | 2003 |
Cologne high-dose sequential chemotherapy in relapsed and refractory Hodgkin lymphoma: results of a large multicenter study of the German Hodgkin Lymphoma Study Group (GHSG).
Topics: Adolescent; Adult; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dexamethasone; Disease-Free Survival; Dose-Response Relationship, Drug; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Hodgkin Disease; Humans; Infusions, Intravenous; Injections, Subcutaneous; Male; Melphalan; Methotrexate; Middle Aged; Peripheral Blood Stem Cell Transplantation; Recurrence; Treatment Outcome; Vincristine | 2005 |
Response to chemotherapy and treating institution predict survival in primary central nervous system lymphoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Central Nervous System Neoplasms; Combined Modality Therapy; Dexamethasone; Female; Humans; Leucovorin; Lymphoma; Male; Methotrexate; Middle Aged; Procarbazine; Survival Rate; Treatment Outcome | 2005 |
High-dose chemotherapy with autologous stem-cell transplantation and hyperfractionated radiotherapy as first-line treatment of primary CNS lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Central Nervous System Neoplasms; Chemotherapy, Adjuvant; Cranial Irradiation; Cytarabine; Dose Fractionation, Radiation; Drug Administration Schedule; Female; Germany; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma; Male; Methotrexate; Middle Aged; Radiotherapy, Adjuvant; Thiotepa; Transplantation, Autologous; Treatment Outcome | 2006 |
High-dose chemotherapy with autologous stem cell transplantation as first-line therapy for primary CNS lymphoma in patients younger than 60 years: a multicenter phase II study of the GOELAMS group.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Central Nervous System Neoplasms; Combined Modality Therapy; Cytarabine; Disease-Free Survival; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Lymphoma; Male; Methotrexate; Methylprednisolone; Middle Aged; Remission Induction; Stem Cell Transplantation; Transplantation, Autologous | 2006 |
Combination chemotherapy followed by autologous stem cell transplant for enteropathy-associated T cell lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Celiac Disease; Combined Modality Therapy; Cytarabine; Enteral Nutrition; Epirubicin; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Ifosfamide; Immunosuppressive Agents; Lymphoma, T-Cell, Peripheral; Male; Melphalan; Methotrexate; Middle Aged; Peripheral Blood Stem Cell Transplantation; Podophyllotoxin; Transplantation Conditioning; Transplantation, Autologous; Treatment Outcome | 2007 |
CHOD/BVAM chemotherapy and whole-brain radiotherapy for newly diagnosed primary central nervous system lymphoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Central Nervous System Neoplasms; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide; Cytarabine; Dexamethasone; Disease Progression; Doxorubicin; Female; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Radiotherapy Dosage; Remission Induction; Vincristine | 2011 |
High-dose chemotherapy with autologous haemopoietic stem cell transplantation for newly diagnosed primary CNS lymphoma: a prospective, single-arm, phase 2 trial.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Central Nervous System Neoplasms; Combined Modality Therapy; Female; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prognosis; Prospective Studies; Rituximab; Survival Rate; Thiotepa; Transplantation, Autologous; Young Adult | 2016 |
LEAM versus CBV for conditioning in autologous hematopoietic stem cell transplantation for lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cyclophosphamide; Doxorubicin; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Lomustine; Lymphoma; Male; Methotrexate; Prednisolone; Prospective Studies; Transplantation Conditioning; Transplantation, Autologous | 2019 |
Bleomycin, vinblastine and dacarbazine combined with nonpegylated liposomal doxorubicin (MBVD) in elderly (≥70 years) or cardiopathic patients with Hodgkin lymphoma: a phase-II study from Fondazione Italiana Linfomi (FIL).
Topics: Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cardiotoxicity; Carmustine; Combined Modality Therapy; Female; Heart Diseases; Hodgkin Disease; Humans; Male; Methotrexate; Methylprednisolone; Neoplasm Staging; Prognosis; Recurrence; Remission Induction; Survival Analysis; Teniposide; Treatment Outcome | 2019 |
142 other study(ies) available for carmustine and methotrexate
Article | Year |
---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
QSPR modeling of octanol/water partition coefficient of antineoplastic agents by balance of correlations.
Topics: Antineoplastic Agents; Models, Chemical; Octanols; Quantitative Structure-Activity Relationship; Water | 2010 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
In vitro inhibition of the bile salt export pump correlates with risk of cholestatic drug-induced liver injury in humans.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Cholestasis; Drug-Related Side Effects and Adverse Reactions; Humans; Insecta; Rats; Risk Factors | 2012 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Combination chemotherapy of Rauscher leukemia and ascites tumors by narcissus alkaloid with standard drugs and effect on cellular immunity.
Topics: Alkaloids; Animals; Antineoplastic Agents; Azacitidine; Blood Cells; Carcinoma, Ehrlich Tumor; Carmustine; Cells, Cultured; Cyclophosphamide; Dactinomycin; Daunorubicin; Drug Synergism; Drug Therapy, Combination; Emetine; Leukemia, Experimental; Leukemia, Lymphoid; Methotrexate; Mice; Mice, Inbred BALB C; Plants, Medicinal; Rauscher Virus; Spleen; Streptonigrin; Vincristine | 1975 |
Effects of antineoplastic agents on wound healing in mice.
Topics: Animals; Antineoplastic Agents; Bleomycin; Carmustine; Cyclophosphamide; Dactinomycin; Doxorubicin; Fluorouracil; Injections, Intraperitoneal; Male; Melanoma; Methotrexate; Mice; Neoplasms, Experimental; Vincristine; Wound Healing | 1975 |
Effect of surgical and chemotherapeutic treatment on alpha-fetoprotein levels in patients with hepatocellular carcinoma.
Topics: alpha-Fetoproteins; Carmustine; Fetal Proteins; Humans; Liver Neoplasms; Methotrexate; Recurrence | 1976 |
[Chemotherapy in bronchogenic carcinoma (author's transl)].
Topics: Antineoplastic Agents; Bleomycin; Carcinoma, Bronchogenic; Carmustine; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Humans; Lomustine; Lung Neoplasms; Mechlorethamine; Methotrexate; Procarbazine; Vinblastine | 1977 |
Quantitation of differential sensitivity of human-tumor stem cells to anticancer drugs.
Topics: Antineoplastic Agents; Bleomycin; Carmustine; Clone Cells; Doxorubicin; Drug Resistance; Female; Hematopoietic Stem Cells; Humans; Melphalan; Methotrexate; Multiple Myeloma; Ovarian Neoplasms; Prognosis; Prospective Studies; Retrospective Studies; Vinblastine | 1978 |
Chemotherapy studies in autochthonous rat tumors: carcinomas of the forestomach.
Topics: Animals; Antineoplastic Agents; Bleomycin; Carmustine; Dimethylnitrosamine; Drug Evaluation, Preclinical; Fluorouracil; Male; Methotrexate; Neoplasms, Experimental; Rats; Stomach Neoplasms | 1979 |
[Treatment of primary and secondary liver tumors using a combination of chemotherapy and surgery].
Topics: Antineoplastic Agents; Carmustine; Drug Therapy, Combination; Floxuridine; Fluorouracil; Humans; Leucovorin; Liver Neoplasms; Methods; Methotrexate; Remission, Spontaneous; Vincristine | 1975 |
Regression of established tumors and induction of tumor immunity by intratumor chemotherapy.
Topics: Animals; Antineoplastic Agents; Carcinoma, Hepatocellular; Carmustine; Dacarbazine; Dactinomycin; Doxorubicin; Drug Therapy, Combination; Fluorouracil; Graft Rejection; Guinea Pigs; Injections; Injections, Intraperitoneal; Liver Neoplasms; Melphalan; Mercaptopurine; Methotrexate; Mitomycins; Neoplasm Transplantation; Neoplasms, Experimental | 1976 |
Acute leukemia complicating treatment of glioblastoma multiforme.
Topics: Antineoplastic Agents; Brain Neoplasms; Carmustine; Child, Preschool; Dexamethasone; Drug Therapy, Combination; Female; Glioblastoma; Humans; Leucovorin; Leukemia, Myeloid, Acute; Leukemia, Radiation-Induced; Methotrexate; Neoplasms, Multiple Primary | 1978 |
Intensive induction therapy for small cell carcinoma of the lung.
Topics: Aged; Antineoplastic Agents; Bone Marrow; Carcinoma, Small Cell; Carmustine; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Etoposide; Female; Humans; Lung Neoplasms; Male; Methotrexate; Middle Aged; Procarbazine; Remission, Spontaneous; Vincristine | 1979 |
[(Meningeal carcinomatosis in patients with breast cancer)].
Topics: Adult; Aged; Breast Neoplasms; Carmustine; Female; Humans; Injections, Spinal; Mastectomy; Meningeal Neoplasms; Methotrexate; Middle Aged | 1979 |
[Synergistic therapeutic effect of adriamycin with 5-fluor-uracil, with prednisolon and with cyclophosphamide on chemically induced mammary cancer of the rat (author's transl)].
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Antineoplastic Agents; Carmustine; Cyclophosphamide; Doxorubicin; Drug Synergism; Drug Therapy, Combination; Female; Fluorouracil; Mammary Neoplasms, Experimental; Methotrexate; Prednisolone; Rats; Vincristine | 1977 |
Methotrexate, cytosine arabinoside, and BCNU concentration in brain after ventriculocisternal perfusion.
Topics: Animals; Brain; Carmustine; Cisterna Magna; Cytarabine; Extracellular Space; Haplorhini; Injections, Intraventricular; Macaca mulatta; Methotrexate; Models, Biological; Perfusion; Time Factors | 1977 |
Paraneoplastic syndrome in childhood.
Topics: Brain Diseases; Carmustine; Child, Preschool; Humans; Lomustine; Male; Mediastinal Neoplasms; Methotrexate; Neuroblastoma; Syndrome | 1977 |
Chemotherapy in recurrent noncystic low-grade astrocytomas of the cerebrum in children.
Topics: Antineoplastic Agents; Astrocytoma; Brain Neoplasms; Carmustine; Child; Child, Preschool; Dexamethasone; Drug Therapy, Combination; Female; Humans; Infant; Male; Methotrexate; Neoplasm Recurrence, Local; Remission, Spontaneous; Vincristine | 1978 |
[Current state of therapy for gastrointestinal tumors].
Topics: Carmustine; Colonic Neoplasms; Drug Therapy, Combination; Fluorouracil; Gastrointestinal Neoplasms; Humans; Methotrexate; Pancreatic Neoplasms; Prognosis; Remission, Spontaneous; Stomach Neoplasms; Vincristine | 1978 |
Rationale of chemotherapeutic adjuvant treatment.
Topics: Animals; Antibiotics, Antineoplastic; Antineoplastic Agents; Carmustine; Cyclophosphamide; Drug Administration Schedule; Fluorouracil; Humans; Leukemia L1210; Lomustine; Mercaptopurine; Methotrexate; Mice; Neoplasms | 1978 |
Interrelationship between chemotherapy and immunotherapy in the treatment of disseminated disease.
Topics: Animals; Carmustine; Dacarbazine; Humans; Immunity; Immunotherapy; Leukemia L1210; Methotrexate; Mice; Mice, Inbred BALB C; Neoplasms | 1978 |
Combination chemotherapy in recurrent medulloblastoma.
Topics: Adolescent; Antineoplastic Agents; Brain Neoplasms; Carmustine; Child; Child, Preschool; Dexamethasone; Drug Therapy, Combination; Female; Humans; Male; Medulloblastoma; Methotrexate; Recurrence; Remission, Spontaneous; Time Factors; Vincristine | 1979 |
Neurosurgical aspects of supratentorial malignant gliomas.
Topics: Biopsy; Brain Neoplasms; Carmustine; Craniotomy; Glioma; Methotrexate | 1976 |
The modification of gastrointestinal tolerance and responses to abdominal irradiation by chemotherapeutic agents.
Topics: Animals; Antineoplastic Agents; Carmustine; Cell Survival; Cyclophosphamide; Intestinal Mucosa; Intestines; Lethal Dose 50; Male; Methotrexate; Mice; Mice, Inbred DBA; Radiation Effects; Stomach; Time Factors | 1976 |
Chemotherapy of brain tumors.
Topics: Brain Neoplasms; Carmustine; Drug Combinations; Glioma; Humans; Lomustine; Methotrexate; Podophyllotoxin; Vincristine | 1976 |
Combination chemotherapy with 4'Demethylepipodophyllotoxin 9-(4,6-0-ethylidene-beta-D-glucopyranoside), VP 16-213 (NSC 141540) in L1210 leukemia.
Topics: Animals; Antineoplastic Agents; Carmustine; Cyclophosphamide; Cytarabine; Dactinomycin; Daunorubicin; Drug Therapy, Combination; Etoposide; Female; Fluorouracil; Leukemia L1210; Male; Mercaptopurine; Methotrexate; Mice; Mice, Inbred DBA; Podophyllotoxin; Vincristine | 1976 |
Electronic volume analysis of L1210 chemotherapy.
Topics: Animals; Antineoplastic Agents; Carmustine; Cell Count; Cell Division; Cell Survival; Cyclophosphamide; Cytarabine; Drug Evaluation, Preclinical; Electronics; Female; Leukemia L1210; Methotrexate; Mice; Time Factors; Vincristine | 1976 |
Screening of cytotoxic drugs for residual bone marrow damage.
Topics: Animals; Antineoplastic Agents; Bone Marrow; Bone Marrow Diseases; Busulfan; Carmustine; Cell Survival; Cyclophosphamide; Drug Evaluation, Preclinical; Female; Fluorouracil; Hematopoietic Stem Cells; Mercaptopurine; Methotrexate; Mice; Mice, Inbred BALB C; Vinblastine | 1976 |
Treatment of acute leukemia in adults.
Topics: Adolescent; Adult; Aged; Asparaginase; Carmustine; Child; Cytarabine; Daunorubicin; Female; Humans; Hydroxyurea; Leukemia, Lymphoid; Leukemia, Monocytic, Acute; Leukemia, Myeloid, Acute; Male; Methotrexate; Middle Aged; Remission, Spontaneous; Thioguanine; Vincristine | 1975 |
Acute lymphoblastic leukemia in adults and children. Differences in response with similar therapeutic regimens.
Topics: Adolescent; Adult; Age Factors; Aged; Asparaginase; Brain Neoplasms; Carmustine; Child; Child, Preschool; Cytarabine; Daunorubicin; Drug Therapy, Combination; Humans; Infant; Injections, Spinal; Leukemia, Lymphoid; Male; Methotrexate; Middle Aged; Prednisone; Remission, Spontaneous; Spinal Neoplasms; Thioguanine; Vincristine | 1976 |
Chemotherapy of primary malignant brain tumors in children.
Topics: Antineoplastic Agents; Brain Neoplasms; Brain Stem; Carmustine; Child; Ependymoma; Glioma; Humans; Medulloblastoma; Methotrexate; Nitrosourea Compounds; Podophyllotoxin; Procarbazine; Vincristine | 1975 |
Editorial: Brain tumor. Current status of treatment and its complications.
Topics: Brain Neoplasms; Carcinoma; Carmustine; Glioma; Humans; Meninges; Methotrexate; Neoplasm Metastasis; Nitrosourea Compounds | 1975 |
Non-Hodgkin's lymphoma in children.
Topics: Adolescent; Asparaginase; Bone Marrow; Brain Neoplasms; Carmustine; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Daunorubicin; Female; Humans; Hydroxyurea; Lymphoma; Male; Methotrexate; Neoplasm Metastasis; Nitrogen Mustard Compounds; Peripheral Nervous System Neoplasms; Prednisone; Prognosis; Thioguanine; Vincristine | 1975 |
Non-Hodgkin's lymphoma in children. A comparative study of two modalities of therapy.
Topics: Adolescent; Antineoplastic Agents; Asparaginase; Carmustine; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Dactinomycin; Daunorubicin; Drug Therapy, Combination; Female; Humans; Hydroxyurea; Lymphoma; Male; Mercaptopurine; Methotrexate; Neoplasm Metastasis; Prednisone; Thioguanine; Vinblastine; Vincristine | 1976 |
Effect of etoposide, carmustine, vincristine, 5-fluorouracil, or methotrexate on radiobiologically oxic and hypoxic cells in a C3H mouse mammary carcinoma in situ.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma in Situ; Carmustine; Cell Division; Cell Hypoxia; Combined Modality Therapy; Etoposide; Female; Fluorouracil; Male; Mammary Neoplasms, Experimental; Methotrexate; Mice; Mice, Inbred C3H; Vincristine | 1992 |
Primary non-Hodgkin's lymphoma of the central nervous system: phase II study of chemotherapy (BVAM) prior to radiotherapy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brain Neoplasms; Carmustine; Combined Modality Therapy; Cytarabine; Drug Evaluation; Female; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prognosis; Radiotherapy Dosage; Time Factors; Vincristine | 1991 |
Combined chemotherapy with bleomycin, adriamycin, and platinum in advanced thyroid cancer.
Topics: Adenocarcinoma; Adult; Aged; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Betamethasone; Bleomycin; Carcinoma; Carmustine; Cisplatin; Doxorubicin; Female; Fluorouracil; Humans; Male; Methotrexate; Metoclopramide; Middle Aged; Nausea; Thyroid Neoplasms; Vincristine | 1991 |
Alteration of the inner surface of venous catheters by antineoplastic drugs.
Topics: Antineoplastic Agents; Bleomycin; Carmustine; Catheterization, Peripheral; Cisplatin; Contrast Media; Doxorubicin; Equipment Design; Fluorouracil; Ifosfamide; Materials Testing; Methotrexate; Microscopy, Electron; Polyurethanes; Rheology; Silicones; Stress, Mechanical; Surface Properties; Tensile Strength; Time Factors; Vincristine | 1991 |
[Preleukemia myelodysplastic syndrome after chemotherapy for multiple myeloma: "a new case"].
Topics: Aged; Anemia, Refractory, with Excess of Blasts; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cyclophosphamide; Humans; Male; Melphalan; Methotrexate; Multiple Myeloma; Prednisone; Risk; Vincristine | 1991 |
Antitumor potential of low-dose chemotherapy manifested in combination with immunotherapy of Viva-Natural, a dietary seaweed extract, on Lewis lung carcinoma.
Topics: Animals; Antineoplastic Agents, Phytogenic; Carmustine; Doxorubicin; Immunotherapy; Lung Neoplasms; Macrophage Activation; Methotrexate; Mice; Mice, Inbred C57BL; Neoplasms, Experimental; Seaweed | 1990 |
Combined intraarterial and systemic chemotherapy for intracerebral tumors.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brain Neoplasms; Carmustine; Cisplatin; Glioma; Glycerol; Humans; Infusions, Intra-Arterial; Infusions, Intravenous; Methotrexate; Middle Aged; Procarbazine; Teniposide; Vincristine | 1987 |
[Combined modality treatment of small cell lung cancer by chemotherapy, radiotherapy, immunotherapy and Chinese traditional medicine].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Carmustine; Combined Modality Therapy; Cyclophosphamide; Drugs, Chinese Herbal; Female; Humans; Levamisole; Lung Neoplasms; Male; Methotrexate; Middle Aged; Vincristine | 1989 |
New xenograft model for assessing experimental therapy of central nervous system tumors: human glioblastoma in the intrathecal compartment of the nude mouse.
Topics: Animals; Carmustine; Cell Line; Disease Models, Animal; Drug Screening Assays, Antitumor; Glioma; Humans; Injections, Intraperitoneal; Injections, Spinal; Male; Methotrexate; Mice; Mice, Nude; Neoplasm Invasiveness; Neoplasm Transplantation; Neoplasms, Nerve Tissue; Spinal Cord; Time Factors; Transplantation, Heterologous | 1988 |
[Rationale and current results of loco-regional chemotherapy in hepatic metastases of colorectal carcinoma].
Topics: Antineoplastic Agents; Carmustine; Cisplatin; Colorectal Neoplasms; Doxorubicin; Floxuridine; Fluorouracil; Humans; Infusions, Intra-Arterial; Liver Neoplasms; Methotrexate; Mitomycin; Mitomycins; Models, Biological; Prognosis | 1987 |
Results of recent salvage chemotherapy regimens for lymphoma and Hodgkin's disease.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carmustine; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dexamethasone; Drug Evaluation; Etoposide; Humans; Ifosfamide; Lymphoma; Methotrexate; Methylprednisolone; Mitoguazone; Transplantation, Autologous | 1988 |
Intraocular involvement of Burkitt's lymphoma in a Bedouin child.
Topics: Abdominal Neoplasms; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Burkitt Lymphoma; Carmustine; Child, Preschool; Cyclophosphamide; Cytarabine; Etoposide; Eye Neoplasms; Female; Humans; Hydrocortisone; Methotrexate; Vincristine; Vitreous Body | 1987 |
Ifosfamide and VP-16213 combination chemotherapy combined with ablative chemotherapy and autologous marrow transplantation as salvage treatment for malignant lymphoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carmustine; Combined Modality Therapy; Cytarabine; Etoposide; Humans; Ifosfamide; Lymphoma; Melphalan; Methotrexate; Middle Aged; Mitoguazone; Podophyllotoxin | 1988 |
Cytosine arabinoside for induction, salvage, and consolidation therapy of adult acute lymphoblastic leukemia.
Topics: Adult; Amsacrine; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carmustine; Cyclophosphamide; Cytarabine; Daunorubicin; Humans; Leukemia, Lymphoid; Methotrexate; Middle Aged; Prednisone; Thioguanine; Vincristine | 1987 |
Factors of prognostic importance in childhood non-Hodgkin's lymphoma treated with two modified LSA2-L2 protocols. A multivariate analysis approach.
Topics: Abdominal Neoplasms; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Blood Cell Count; Carmustine; Child; Child, Preschool; Cyclophosphamide; Daunorubicin; Drug Administration Schedule; Female; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Nutritional Status; Prednisone; Prognosis; Time Factors; Vincristine | 1988 |
[Treatment of acute adult myeloblastic leukemia with intensive chemotherapy].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Carmustine; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Doxorubicin; Drug Combinations; Drug Evaluation; Female; Humans; Leukemia, Myeloid, Acute; Male; Meningeal Neoplasms; Mercaptopurine; Methotrexate; Middle Aged; Mitoguazone; Prednisone; Thioguanine; Vincristine | 1986 |
Very high dose chemotherapy with autologous bone marrow rescue in adult patients with resistant relapsed lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carmustine; Cyclophosphamide; Cytarabine; Female; Hodgkin Disease; Humans; Lymphoma; Male; Melphalan; Methotrexate; Middle Aged; Podophyllotoxin | 1986 |
Successful non-neurotoxic therapy (without radiation) of a multifocal primary brain lymphoma with a methotrexate, vincristine, and BCNU protocol (DEMOB).
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carmustine; Child, Preschool; Dexamethasone; Humans; Kinetics; Lymphoma; Male; Methotrexate; Vincristine | 1986 |
The enhanced therapeutic effect of cis-platinum (II) diamminodichloride against L1210 leukemia when combined with cyclophosphamide or 1,2-bis(3,5-dioxopiperazine-1-yl)propane or several other antitumor agents.
Topics: Amines; Animals; Antineoplastic Agents; Azacitidine; Camptothecin; Carmustine; Chlorides; Cyclophosphamide; Cytarabine; Drug Synergism; Emetine; Fluorouracil; Ketones; Leukemia L1210; Male; Methotrexate; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Piperazines; Platinum; Propane; Time Factors | 1973 |
Comparative effects of cytotoxic agents on transplanted hematopoietic and antibody-producing cells.
Topics: Animals; Antibody Formation; Antibody-Producing Cells; Antilymphocyte Serum; Antineoplastic Agents; Carmustine; Cell Division; Cyclophosphamide; Dactinomycin; Female; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Immunization, Passive; Mercaptopurine; Methotrexate; Mice; Mice, Inbred Strains; Models, Biological; Spleen; Time Factors; Transplantation, Homologous | 1973 |
Comparative effects of selected cytotoxic agents on transplanted hematopoietic cells.
Topics: Animals; Bone Marrow Cells; Bone Marrow Transplantation; Busulfan; Carmustine; Cell Survival; Cortisone; Cyclophosphamide; Graft vs Host Reaction; Immunosuppression Therapy; Mercaptopurine; Methotrexate; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Time Factors; Transplantation Immunology; Transplantation, Homologous; Vincristine | 1972 |
Sequential administration of two oncostatic drugs: study of modalities for pharmacodynamic potentiation.
Topics: Animals; Antineoplastic Agents; Carmustine; Cyclophosphamide; Cytarabine; Dactinomycin; Drug Synergism; Drug Therapy, Combination; Female; Fluorouracil; Kinetics; Leukemia L1210; Lomustine; Mathematics; Methotrexate; Mice; Mitomycins; Neoplasm Transplantation; Nitrosourea Compounds; Time Factors; Vincristine | 1974 |
Combination chemotherapy for spontaneous AKR lymphoma.
Topics: Animals; Antineoplastic Agents; Biological Assay; Carmustine; Cyclohexanes; Cyclophosphamide; Cytarabine; Disease Models, Animal; Doxorubicin; Drug Therapy, Combination; Lymphoma; Methotrexate; Mice; Mice, Inbred AKR; Neoplasms, Experimental; Nitrosourea Compounds; Organ Size; Palmitic Acids; Prednisone; Remission, Spontaneous; Rodent Diseases; Spleen; Splenomegaly; Thymus Gland; Time Factors; Vincristine | 1974 |
Intensive chemotherapy in children with acute lymphoblastic leukemia (L-2 protocol).
Topics: Administration, Oral; Adolescent; Age Factors; Antineoplastic Agents; Asparaginase; Carmustine; Chemical and Drug Induced Liver Injury; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Daunorubicin; Drug Therapy, Combination; Evaluation Studies as Topic; Female; Follow-Up Studies; Humans; Hydroxyurea; Infant; Infections; Injections, Intravenous; Leukemia, Lymphoid; Male; Meningitis; Methotrexate; Prednisone; Remission, Spontaneous; Thioguanine; Vincristine | 1974 |
Comparative results obtained in the treatment of acute leukemia.
Topics: Antineoplastic Agents; Asparaginase; Carmustine; Cytarabine; Daunorubicin; Drug Therapy, Combination; Humans; Hydroxyurea; Leukemia; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Meningitis; Methotrexate; Prednisone; Thioguanine; Vincristine | 1973 |
[Neuromeningeal irradiation during the treatment of acute lymphoblastic leukemia].
Topics: Acute Disease; Age Factors; Asparaginase; Carmustine; Central Nervous System; Child; Child, Preschool; Cobalt Radioisotopes; Cyclophosphamide; Female; Humans; Leukemia, Lymphoid; Male; Methotrexate; Prednisone; Radioisotope Teletherapy; Radiotherapy Dosage; Time Factors; Vincristine | 1974 |
Influence of chemotherapeutic agents on the antibacterial activity of normal and leukemic sera.
Topics: Antineoplastic Agents; Blood Bactericidal Activity; Carmustine; Cell Membrane; Complement System Proteins; Cyclophosphamide; Cytarabine; Daunorubicin; Dose-Response Relationship, Drug; Escherichia coli; Fluorouracil; Humans; Immunoglobulins; Leukemia; Mechlorethamine; Methotrexate; Microbial Sensitivity Tests; Muramidase; Prednisone; Vincristine | 1974 |
Combination therapy of solid tumors using 1,3-bis(2-chloroethyl)-1-nitrosourea (NCNU), vincristine, methotrexate, and 5-fluorouracil.
Topics: Adenocarcinoma; Adult; Aged; Carcinoma, Squamous Cell; Carmustine; Female; Fluorouracil; Gastrointestinal Neoplasms; Humans; Liver Neoplasms; Lung Neoplasms; Male; Methotrexate; Middle Aged; Neoplasm Metastasis; Neoplasms; Thyroid Neoplasms; Uterine Neoplasms; Vincristine | 1973 |
Increased life-span in AKR leukemia mice treated with prophylactic chemotherapy.
Topics: Animals; Carmustine; Cyclophosphamide; Evaluation Studies as Topic; Leukemia, Experimental; Methotrexate; Mice; Mice, Inbred AKR; Prognosis; Time Factors | 1973 |
Necrotizing encephalopathy following intraventricular instillation of methotrexate.
Topics: Adolescent; Brain; Brain Diseases; Brain Neoplasms; Carmustine; Cerebellar Neoplasms; Cerebral Ventricle Neoplasms; Cerebral Ventricles; Child; Female; Glioma; Humans; Injections, Spinal; Leukemia; Lymphoma, Non-Hodgkin; Male; Medulloblastoma; Methotrexate; Middle Aged | 1973 |
Analysis of tests of chemotherapeutic agents involving repeated drug treatment.
Topics: Animals; Antineoplastic Agents; Carmustine; Drug Evaluation, Preclinical; Drug Resistance; Leukemia L1210; Methotrexate; Mice; Models, Biological; Time Factors | 1973 |
Evaluation of anti-tumor agents on tRNA methylase activity of leukemia L1210.
Topics: Animals; Antineoplastic Agents; Carbon Isotopes; Carmustine; Cell Count; Cells, Cultured; Depression, Chemical; In Vitro Techniques; Leucine; Leukemia L1210; Methotrexate; Methyltransferases; Mice; Neoplasm Proteins; Poly I-C; RNA, Transfer; Vincristine | 1972 |
The effect of chemotherapeutic agents on the incorporation of DNA precursors by experimental brain tumors.
Topics: Animals; Antineoplastic Agents; Blood-Brain Barrier; Bone Marrow; Brain; Brain Neoplasms; Carbon Isotopes; Carmustine; Cyclohexanes; Cytarabine; Deoxyuridine; Disease Models, Animal; DNA, Neoplasm; Dose-Response Relationship, Drug; Ependymoma; Glioma; Lymph Nodes; Male; Methotrexate; Mice; Mice, Inbred C57BL; Neoplasm Transplantation; Neoplasms, Experimental; Nitrosourea Compounds; Thymidine; Tritium | 1972 |
[Growth of tumour-cell colonies from human solid tumours (author's transl)].
Topics: Carmustine; Cisplatin; Clone Cells; Doxorubicin; Drug Resistance; Fluorouracil; Humans; In Vitro Techniques; Interferons; Methods; Methotrexate; Neoplasms | 1982 |
Combination chemotherapy with vincristine, carmustine, carmustine (BCNU), and bleomycin in patients with squamous cell bronchial carcinoma resistant to cyclophosphamide, doxorubicin, methotrexate, and procarbazine (CAMP).
Topics: Adult; Aged; Bleomycin; Bronchial Neoplasms; Carcinoma, Squamous Cell; Carmustine; Cyclophosphamide; Doxorubicin; Drug Evaluation; Female; Humans; Male; Methotrexate; Middle Aged; Procarbazine; Vincristine | 1982 |
Effect of pH and elevated temperatures on the cytotoxicity of some chemotherapeutic agents on Chinese hamster cells in vitro.
Topics: Amphotericin B; Animals; Antineoplastic Agents; Bleomycin; Carmustine; Cell Line; Cell Survival; Cricetinae; Cricetulus; Hot Temperature; Hydrogen-Ion Concentration; Kinetics; Methotrexate | 1983 |
Correlation of intralesional in vivo chemotherapy of line 10 hepatoma with in vitro drug sensitivity.
Topics: Animals; Antineoplastic Agents; Bleomycin; Carmustine; Cell Line; Cisplatin; Dactinomycin; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Female; Fluorouracil; Guinea Pigs; Liver Neoplasms, Experimental; Methotrexate; Neoplastic Stem Cells; Stem Cells; Vincristine | 1983 |
Primitive neuroectodermal tumors of childhood. An approach to therapy.
Topics: Adolescent; Antineoplastic Agents; Brain Neoplasms; Carmustine; Child; Dexamethasone; Drug Therapy, Combination; Female; Humans; Leucovorin; Male; Methotrexate; Neoplasms, Germ Cell and Embryonal; Procarbazine; Radiotherapy, High-Energy; Vincristine | 1981 |
New implantable continuous administration and bolus dose intracarotid drug delivery system for the treatment of malignant gliomas.
Topics: Adult; Animals; Antineoplastic Agents; Brain Neoplasms; Carmustine; Carotid Arteries; Chemotherapy, Cancer, Regional Perfusion; Female; Floxuridine; Glioblastoma; Humans; Macaca mulatta; Male; Methotrexate; Middle Aged | 1982 |
In vitro radiation and chemotherapy sensitivity of established cell lines of human small cell lung cancer and its large cell morphological variants.
Topics: Antineoplastic Agents; Carcinoma, Small Cell; Carmustine; Cell Line; Cell Survival; Dose-Response Relationship, Radiation; Doxorubicin; Humans; In Vitro Techniques; Lung Neoplasms; Methotrexate; Vincristine | 1983 |
Interaction between human lymphoblastoid interferon and chemotherapeutic agents in vitro.
Topics: Antineoplastic Agents; B-Lymphocytes; Carmustine; Cyclophosphamide; Cytarabine; DNA Replication; Doxorubicin; Drug Therapy, Combination; Humans; In Vitro Techniques; Interferon Type I; Leukemia, Lymphoid; Methotrexate; T-Lymphocytes | 1984 |
Decreased phenytoin level during antineoplastic therapy: a case report.
Topics: Antineoplastic Agents; Brain Neoplasms; Carmustine; Drug Interactions; Drug Therapy, Combination; Humans; Male; Methotrexate; Middle Aged; Phenobarbital; Phenytoin; Seizures; Vinblastine | 1983 |
Effect of heating on lethality due to hyperthermia and selected chemotherapeutic drugs.
Topics: Animals; Antineoplastic Agents; Carmustine; Cell Survival; Cells, Cultured; Cisplatin; Cricetinae; Cricetulus; Dose-Response Relationship, Drug; Doxorubicin; Female; Hot Temperature; Methotrexate; Neoplasms, Experimental; Ovary; Time Factors | 1982 |
Treatment of patients with refractory myelogenous leukemia with BCOMM[1,3-bis-chloro(2-chloroethyl)-1-nitrosourea (BCNU), oncovin (vincristine), cyclophosphamide, high-dose methotrexate and methyl-glyoxal bis-guanylhydrazone (MGBG)].
Topics: Adolescent; Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Child; Cyclophosphamide; Drug Therapy, Combination; Humans; Leukemia, Myeloid, Acute; Methotrexate; Middle Aged; Mitoguazone; Vincristine | 1982 |
Acute nonlymphoblastic leukemia: prognostic factors in adults with long-term follow-up.
Topics: Acute Disease; Adolescent; Adult; Age Factors; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bacterial Vaccines; Carmustine; Cyclophosphamide; Cytarabine; Daunorubicin; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Hydroxyurea; Leukemia; Male; Methotrexate; Middle Aged; Platelet Count; Prognosis; Pseudomonas; Statistics as Topic; Thioguanine; Vincristine | 1982 |
Management of drug toxicities and infections.
Topics: Antineoplastic Agents; Carmustine; Cisplatin; Cyclophosphamide; Dacarbazine; Humans; Infections; Methotrexate; Neoplasms | 1980 |
A five-drug combination in the treatment of metastatic breast cancer.
Topics: Antineoplastic Agents; Breast Neoplasms; Carmustine; Dacarbazine; Drug Therapy, Combination; Female; Fluorouracil; Humans; Methotrexate; Neoplasm Metastasis; Prednisone | 1981 |
Establishment of a cloned line of Lewis Lung Carcinoma cells adapted to cell culture.
Topics: Animals; Carmustine; Cell Line; Clone Cells; Graft Survival; Humans; Lung Neoplasms; Methotrexate; Mice; Mice, Inbred C57BL; Neoplasm Transplantation; Neoplasms, Experimental; Transplantation, Heterologous | 1980 |
Peritoneal exudate mononuclear phagocyte colony-forming cells: their proliferative state in vivo and sensitivity to cytotoxic agents.
Topics: Animals; Ascitic Fluid; Autoradiography; Carmustine; Cell Division; Colony-Forming Units Assay; Cyclophosphamide; Cytarabine; Female; Hematopoietic Stem Cells; Macrophages; Male; Mechlorethamine; Methotrexate; Mice; Mice, Inbred C3H; Thymidine; Tritium; Vinblastine | 1980 |
Plasma levels of cyclophosphamide in patients under polychemotherapeutic regimens.
Topics: Adult; Carmustine; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Half-Life; Humans; Kinetics; Lung Neoplasms; Methotrexate; Middle Aged | 1980 |
Chemotherapy against human melanoma in the hamster cheek pouch.
Topics: Animals; Antineoplastic Agents; Brain Neoplasms; Carmustine; Cheek; Cricetinae; Cyclophosphamide; Dacarbazine; Doxorubicin; Fluorouracil; Humans; Male; Melanoma; Methotrexate; Middle Aged; Neoplasm Transplantation; Neoplasms, Experimental; Vincristine | 1980 |
Chemosensitivity testing of human malignant melanoma. A retrospective analysis of clinical response and in vitro drug sensitivity.
Topics: Antineoplastic Agents; Bleomycin; Carboplatin; Carmustine; Cisplatin; Dacarbazine; Dose-Response Relationship, Drug; Doxorubicin; Drug Resistance; Drug Screening Assays, Antitumor; Fluorouracil; Forecasting; Humans; In Vitro Techniques; Lymphatic Metastasis; Melanoma; Methotrexate; Nitrosourea Compounds; Organophosphorus Compounds; Pilot Projects; Remission Induction; Retrospective Studies; Skin Neoplasms; Tumor Cells, Cultured; Vindesine | 1994 |
Clostridium septicum abscess in hepatic metastases: successful medical management.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Breast Neoplasms; Carmustine; Ceftazidime; Cisplatin; Clindamycin; Clostridium Infections; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Etoposide; Female; Fluorouracil; Gases; Granulocyte Colony-Stimulating Factor; Humans; Imipenem; Immunocompromised Host; Liver Abscess; Liver Neoplasms; Methotrexate; Neutropenia; Sepsis | 1994 |
Visual hallucinations following treatment with vincristine.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carmustine; Cyclophosphamide; Doxorubicin; Etoposide; Hallucinations; Humans; Lymphoma, T-Cell; Male; Melphalan; Methotrexate; Middle Aged; Multiple Myeloma; Prednisolone; Prednisone; Procarbazine; Salvage Therapy; Serotonin; Structure-Activity Relationship; Vincristine | 1994 |
Prolonged impairment of hematopoiesis after high-dose therapy followed by autologous bone marrow transplantation.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Bone Marrow Transplantation; Busulfan; Carmustine; Cell Count; Child; Child, Preschool; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Etoposide; Female; Follow-Up Studies; Hematopoiesis; Hematopoietic Cell Growth Factors; Humans; Male; Melphalan; Methotrexate; Middle Aged; Mitoxantrone; Multivariate Analysis; Neoplasms; Prognosis; Radiation Injuries; Treatment Outcome; Vincristine; Whole-Body Irradiation | 1995 |
Intralesional implant for treatment of primary oral malignant melanoma in dogs.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cisplatin; Delayed-Action Preparations; Dog Diseases; Dogs; Drug Implants; Female; Gels; Injections, Intralesional; Linear Models; Male; Melanoma; Methotrexate; Mouth Neoplasms; Neoplasm Recurrence, Local; Oropharyngeal Neoplasms; Survival Rate; Treatment Outcome | 1994 |
Pneumocystis carinii pneumonia in adults with acute leukaemia: is there a need for primary chemoprophylaxis?
Topics: Aclarubicin; Acute Disease; Adult; Amsacrine; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cohort Studies; Cyclophosphamide; Cytarabine; Daunorubicin; Dexamethasone; Etoposide; Female; Finland; Humans; Immunocompromised Host; Incidence; Leukemia; Male; Mercaptopurine; Methotrexate; Middle Aged; Mitoxantrone; Pneumonia, Pneumocystis; Prednisone; Premedication; Retrospective Studies; Thioguanine; Trimethoprim, Sulfamethoxazole Drug Combination; Vincristine | 1996 |
Successful mobilisation of blood stem cells following previous autologous bone marrow transplantation.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Blood Cells; Bone Marrow; Bone Marrow Transplantation; Carmustine; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Doxorubicin; Epirubicin; Etoposide; Hematopoietic Stem Cells; Humans; Ifosfamide; Leukapheresis; Lymphoma, Follicular; Male; Melphalan; Methotrexate; Podophyllotoxin; Prednisolone; Prednisone; Transplantation Conditioning; Transplantation, Autologous; Vincristine | 1996 |
Positive selection and ex vivo expansion of hematopoietic progenitors as autografts for high-dose chemotherapy, potential importance in patients with bone metastases.
Topics: Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Carmustine; Cisplatin; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Female; Fluorouracil; Hematopoietic Stem Cell Transplantation; Humans; Methotrexate; Neoplasm Staging; Remission Induction; Transplantation, Autologous | 1995 |
Treatment of relapsed non-Hodgkin's lymphoma after BEAM chemotherapy and autologous transplantation by BU/CY chemotherapy and salvage transplantation.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Doxorubicin; Epirubicin; Etoposide; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Injections, Spinal; Lymphoma, B-Cell, Marginal Zone; Male; Melphalan; Methotrexate; Prednisone; Recurrence; Remission Induction; Retreatment; Salvage Therapy; Stomach Neoplasms; Transplantation Conditioning; Tumor Lysis Syndrome; Vincristine | 1997 |
Intensified and high-dose chemotherapy with granulocyte colony-stimulating factor and autologous stem-cell transplantation support as first-line therapy in high-risk diffuse large-cell lymphoma.
Topics: Adult; Antimetabolites, Antineoplastic; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Carmustine; Cyclophosphamide; Cytarabine; Dexamethasone; Disease-Free Survival; Doxorubicin; Etoposide; Feasibility Studies; Female; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Leucovorin; Leukapheresis; Lymphoma, Large B-Cell, Diffuse; Male; Melphalan; Methotrexate; Middle Aged; Mitoxantrone; Pilot Projects; Prednisone; Risk; Survival Analysis; Transplantation, Autologous; Treatment Outcome; Vincristine | 1997 |
Sequential intensive treatment with the F-MACHOP regimen (+/- radiotherapy) and autologous stem cell transplantation for primary systemic CD30 (Ki-1)--positive anaplastic large cell lymphoma in adults.
Topics: Adolescent; Adult; Amsacrine; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cyclophosphamide; Cytarabine; Disease-Free Survival; Doxorubicin; Etoposide; Female; Fluorouracil; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, Large-Cell, Anaplastic; Male; Methotrexate; Middle Aged; Prednisone; Prognosis; Prospective Studies; Remission Induction; Transplantation Conditioning; Transplantation, Autologous; Vincristine | 1997 |
Blast crisis of chronic myelogenous leukemia in long-lasting systemic lupus erythematosus: regression of both diseases after autologous bone marrow transplantation.
Topics: Adult; Amsacrine; Antineoplastic Combined Chemotherapy Protocols; Autoimmune Diseases; Blast Crisis; Bone Marrow Transplantation; Carmustine; Combined Modality Therapy; Cytarabine; Etoposide; Female; Humans; Idarubicin; Immunologic Factors; Interferon-alpha; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lupus Erythematosus, Systemic; Methotrexate; Prednisone; Remission Induction; Transplantation, Autologous; Vincristine | 1997 |
BEAM chemotherapy and autologous haemopoietic progenitor cell transplantation as front-line therapy for high-risk patients with diffuse large cell lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carmustine; Cyclophosphamide; Cytarabine; Disease-Free Survival; Doxorubicin; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Leucovorin; Lymphoma, Large B-Cell, Diffuse; Male; Melphalan; Methotrexate; Middle Aged; Prednisone; Survival Rate; Treatment Outcome; Vincristine | 1997 |
Systemic chemotherapy alone for patients with non-acquired immunodeficiency syndrome-related central nervous system lymphoma: a pilot study of the BOMES protocol.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Central Nervous System Neoplasms; Disease Progression; Etoposide; Female; Humans; Lymphoma, AIDS-Related; Male; Methotrexate; Methylprednisolone Hemisuccinate; Middle Aged; Pilot Projects; Prospective Studies; Survival Rate; Treatment Outcome; Vincristine | 1998 |
Multidrug resistance in glioblastoma. Chemosensitivity testing and immunohistochemical demonstration of P-glycoprotein.
Topics: Antibodies, Monoclonal; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Brain Neoplasms; Carmustine; Cell Survival; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Glioblastoma; Immunohistochemistry; Methotrexate; Mitoxantrone; Nimustine; Tetrazolium Salts; Thiazoles; Tumor Cells, Cultured | 1998 |
Combination chemotherapy with mitoguazon, ifosfamide, MTX, etoposide (MIME) and G-CSF can efficiently mobilize PBPC in patients with Hodgkin's and non-Hodgkin's lymphoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Combined Modality Therapy; Cytarabine; Dexamethasone; Etoposide; Female; Graft Survival; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Hodgkin Disease; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Male; Melphalan; Methotrexate; Middle Aged; Mitoguazone; Salvage Therapy; Time Factors | 1998 |
Successful treatment of non-Hodgkin's lymphoma of the central nervous system with BMPD chemotherapy followed by radiotherapy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Blood-Brain Barrier; Carmustine; Central Nervous System Neoplasms; Combined Modality Therapy; Dexamethasone; Female; Humans; Leucovorin; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Procarbazine; Radiography; Treatment Outcome | 1998 |
Carboxypeptidase G2 rescue in a 79 year-old patient with cranial lymphoma after high-dose methotrexate induced acute renal failure.
Topics: Acute Kidney Injury; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Bacterial Proteins; Carmustine; Combined Modality Therapy; Cyclophosphamide; Dexamethasone; Diuretics; Doxorubicin; Ethmoid Sinus; Female; Fluid Therapy; Folic Acid; Furosemide; gamma-Glutamyl Hydrolase; Humans; Leucovorin; Lymphoma, B-Cell; Lymphoma, Large-Cell, Immunoblastic; Methotrexate; Paranasal Sinus Neoplasms; Prednisone; Procarbazine; Remission Induction; Vincristine | 1999 |
Preliminary experience of allogeneic stem cell transplantation for lymphoproliferative disorders using BEAM-CAMPATH conditioning: an effective regimen with low procedure-related toxicity.
Topics: Adult; Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cyclosporine; Cytarabine; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma; Lymphoproliferative Disorders; Male; Melphalan; Methotrexate; Middle Aged; Podophyllotoxin; Transplantation Conditioning; Transplantation, Homologous | 2000 |
Point mutations of the BCL-6 gene: clinical and prognostic correlation in B-diffuse large cell lymphoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carmustine; Chromosomes, Human, Pair 3; Cyclophosphamide; Cytarabine; Disease-Free Survival; DNA Mutational Analysis; DNA-Binding Proteins; DNA, Neoplasm; Doxorubicin; Etoposide; Female; Genes, bcl-2; Humans; Life Tables; Lymphoma, Large B-Cell, Diffuse; Male; Melphalan; Methotrexate; Middle Aged; Neoplasm Proteins; Neoplasm Staging; Point Mutation; Prednisolone; Prednisone; Prognosis; Proto-Oncogene Mas; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-6; Proto-Oncogenes; Transcription Factors; Treatment Outcome; Vincristine | 2002 |
Long-term results (12 years) of high-dose therapy in 127 patients with de novo multiple myeloma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carmustine; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Female; Humans; Male; Melphalan; Methotrexate; Middle Aged; Multiple Myeloma; Prednisone; Survival Rate; Time Factors; Transplantation, Autologous; Vincristine | 2002 |
Chemosensitization of carmustine with maitake beta-glucan on androgen-independent prostatic cancer cells: involvement of glyoxalase I.
Topics: Agaricales; Androgens; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; beta-Glucans; Carmustine; Cell Survival; Dose-Response Relationship, Drug; Fluorouracil; Glucans; Humans; In Vitro Techniques; Lactoylglutathione Lyase; Male; Methotrexate; Prostatic Neoplasms; Tumor Cells, Cultured | 2002 |
Salvage treatment with etoposide (VP-16), ifosfamide and cytarabine (Ara-C) for patients with recurrent primary central nervous system lymphoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carmustine; Child, Preschool; Clinical Trials, Phase II as Topic; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide; Cytarabine; Dexamethasone; Disease-Free Survival; Doxorubicin; Drug Evaluation; Etoposide; Female; Humans; Ifosfamide; Life Tables; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Neutropenia; Remission Induction; Retrospective Studies; Salvage Therapy; Survival Analysis; Thrombocytopenia; Vincristine | 2003 |
IN VIVO ANTIVIRAL ACTIVITY OF 1,3-BIS(2-CHLOROETHYL)-1-NITROSOUREA.
Topics: Alkylating Agents; Animals; Antiviral Agents; Avian Sarcoma Viruses; Carmustine; Encephalitis Viruses; Enterovirus C, Human; Forests; Herpesviridae; Leukemia Virus, Murine; Lymphocytic Choriomeningitis; Lymphocytic choriomeningitis virus; Methotrexate; Mice; Nitroso Compounds; Nitrosourea Compounds; Orthomyxoviridae; Pharmacology; Poliovirus; Poultry; Research; Rous sarcoma virus; Semliki forest virus; Simplexvirus; Splenomegaly; Urea; Vaccinia virus; Viruses | 1965 |
Intensive methotrexate and cytarabine followed by high-dose chemotherapy with autologous stem-cell rescue in patients with newly diagnosed primary CNS lymphoma: an intent-to-treat analysis.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Central Nervous System Neoplasms; Combined Modality Therapy; Cytarabine; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, Non-Hodgkin; Male; Melphalan; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Prospective Studies; Remission Induction; Safety; Salvage Therapy; Survival Rate; Transplantation, Autologous; Treatment Outcome | 2003 |
Cognitive status and quality of life after treatment for primary CNS lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Atrophy; Brain; Carmustine; Case-Control Studies; Central Nervous System Neoplasms; Cognition Disorders; Cohort Studies; Combined Modality Therapy; Cranial Irradiation; Cytarabine; Female; Humans; Hydrocortisone; Injections, Spinal; Lymphoma, Non-Hodgkin; Male; Methotrexate; Methylprednisolone; Middle Aged; Myelin Sheath; Neuropsychological Tests; Prospective Studies; Quality of Life; Teniposide | 2004 |
Primary non-Hodgkin's lymphoma of the CNS treated with CHOD/BVAM or BVAM chemotherapy before radiotherapy: long-term survival and prognostic factors.
Topics: Adult; Aged; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Central Nervous System Neoplasms; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Female; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Survival Analysis; Vincristine | 2004 |
A spinal cord intravascular lymphomatosis with exceptionally good outcome.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Capillaries; Carmustine; Central Nervous System; Combined Modality Therapy; Female; Humans; Lymphoma, Non-Hodgkin; Magnetic Resonance Imaging; Methotrexate; Methylprednisolone; Paraplegia; Spinal Cord Neoplasms; Teniposide | 2004 |
Combined chemotherapy with carmustine, doxorubicin, etoposide, vincristine, and cyclophosphamide plus mitoxantrone, cytarabine and methotrexate with citrovorum factor for the treatment of aggressive non-Hodgkin lymphoma: a long-term follow-up study.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cyclophosphamide; Cytarabine; Disease-Free Survival; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Follow-Up Studies; Humans; Leucovorin; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Mitoxantrone; Survival Rate; Vincristine | 2005 |
Nephrotic syndrome in patients with peripheral blood stem cell transplant.
Topics: Acute Kidney Injury; Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Busulfan; Carmustine; Combined Modality Therapy; Cyclophosphamide; Cytomegalovirus Infections; Etoposide; Glomerulonephritis, Membranous; Graft vs Host Disease; Humans; Immunosuppressive Agents; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Multiple Myeloma; Nephrotic Syndrome; Peripheral Blood Stem Cell Transplantation; Postoperative Complications; Prednisone; Rituximab; Sepsis; Staphylococcal Infections; Tacrolimus; Transplantation Conditioning | 2005 |
Development of a large-scale chemogenomics database to improve drug candidate selection and to understand mechanisms of chemical toxicity and action.
Topics: 5-Aminolevulinate Synthetase; Animals; Antineoplastic Agents; Automation; Bile Ducts; Biotechnology; Carmustine; Computational Biology; Databases as Topic; Dose-Response Relationship, Drug; Down-Regulation; Drug Design; Drug Industry; Gene Expression; Humans; Hyperplasia; Liver; Male; Methotrexate; Nucleic Acid Hybridization; Oligonucleotide Array Sequence Analysis; Organ Size; Pharmacology; Rats; Rats, Sprague-Dawley; Reticulocytes; RNA; RNA, Complementary; Thioguanine; Time Factors; Tissue Distribution; Toxicology | 2005 |
[Chemotherapy and renal toxicity].
Topics: Angiogenesis Inhibitors; Antineoplastic Agents; Carboplatin; Carmustine; Cisplatin; Deoxycytidine; Gemcitabine; Humans; Kidney; Kidney Diseases; Lomustine; Methotrexate; Organoplatinum Compounds; Oxaliplatin | 2008 |
Development of resistance to adriamycin (NSC-123127) in Ehrlich ascites tumor in vivo.
Topics: Animals; Antibiotics, Antineoplastic; Carcinoma, Ehrlich Tumor; Carmustine; Cytarabine; Dose-Response Relationship, Drug; Doxorubicin; Drug Resistance, Neoplasm; Female; Male; Mercaptopurine; Methotrexate; Mice; Mice, Inbred DBA; Neoplasm Transplantation; Vincristine | 1972 |
Carmustine and methotrexate in combination after whole brain radiation therapy in breast cancer patients presenting with brain metastases: a retrospective study.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Breast Neoplasms; Carmustine; Combined Modality Therapy; Cranial Irradiation; Female; Humans; Methotrexate; Middle Aged; Retrospective Studies; Survival Rate; Treatment Outcome | 2010 |
Isolated central nervous system relapses in primary mediastinal large B-cell lymphoma after CHOP-like chemotherapy with or without Rituximab.
Topics: Adolescent; Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Busulfan; Carmustine; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide; Cytarabine; Doxorubicin; Female; Humans; Incidence; Kaplan-Meier Estimate; Lymphoma, Large B-Cell, Diffuse; Male; Mediastinal Neoplasms; Methotrexate; Methylprednisolone; Middle Aged; Prednisone; Proportional Hazards Models; Retrospective Studies; Risk Factors; Rituximab; Salvage Therapy; Stem Cell Transplantation; Thiotepa; Vincristine; Young Adult | 2013 |
Primary central nervous system diffuse large B cell lymphoma transformed from orbital mucosa-associated lymphoid tissue lymphoma: complete response to combined intrathecal and systemic rituximab.
Topics: Adult; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Clarithromycin; Cranial Irradiation; Cyclophosphamide; Disease Progression; Etoposide; Humans; Immunophenotyping; Immunosuppressive Agents; Injections, Spinal; Lymphoma, B-Cell, Marginal Zone; Lymphoma, Large B-Cell, Diffuse; Male; Meningeal Neoplasms; Methotrexate; Methylprednisolone Hemisuccinate; Orbital Neoplasms; Prednisolone; Remission Induction; Rituximab; Vincristine | 2013 |
Single-agent rituximab for primary CNS lymphoma during pregnancy as a bridge to definitive management.
Topics: Adult; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Brain; Carmustine; Central Nervous System Neoplasms; Cesarean Section; Cytarabine; Dexamethasone; Drug Administration Schedule; Female; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, Large B-Cell, Diffuse; Magnetic Resonance Imaging; Melphalan; Methotrexate; Podophyllotoxin; Pregnancy; Pregnancy Complications, Neoplastic; Pregnancy Outcome; Rituximab; Transplantation, Autologous; Treatment Outcome | 2014 |
[Prognostic impact of anthracyclines in the treatment of aggressive lymphoma in patients over 70 years].
Topics: Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cyclophosphamide; Cytarabine; Disease-Free Survival; Doxorubicin; Etoposide; Female; Humans; Kaplan-Meier Estimate; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Methotrexate; Prednisone; Prognosis; Proportional Hazards Models; Retrospective Studies; Rituximab; Treatment Outcome; Vincristine | 2015 |
Cerebral involvement as the first extracutaneous manifestation of mycosis fungoides.
Topics: Adrenal Cortex Hormones; Antineoplastic Combined Chemotherapy Protocols; Bexarotene; Brain; Carmustine; Combined Modality Therapy; Cytarabine; Disease Progression; Fatal Outcome; Female; Humans; Lymphoma, Large-Cell, Anaplastic; Memory Disorders; Methotrexate; Middle Aged; Mycosis Fungoides; Nystagmus, Pathologic; PUVA Therapy; Skin Neoplasms; Tetrahydronaphthalenes | 2015 |
Examining a role for PKG Iα oxidation in the pathogenesis of cardiovascular dysfunction during diet-induced obesity.
Topics: Animals; Aorta; Carmustine; Cattle; Cyclic GMP-Dependent Protein Kinase Type I; Diet, High-Fat; Endothelial Cells; Gene Expression Regulation; Glucagon; Hypertension; Leptin; Methotrexate; Mice; Myocytes, Smooth Muscle; Nitric Oxide Synthase Type III; Obesity; Oxidation-Reduction; Oxidative Stress; Reactive Oxygen Species; Resistin; Signal Transduction; Sugar Acids; Uncoupling Agents | 2017 |
Treatment of sporadic Burkitt lymphoma in adults, a retrospective comparison of four treatment regimens.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Carmustine; Cost-Benefit Analysis; Cyclophosphamide; Cytarabine; Etoposide; Female; HIV Infections; Humans; Ifosfamide; Male; Melphalan; Methotrexate; Middle Aged; Neoplasm Staging; Retrospective Studies; Rituximab; Survival Analysis | 2018 |
Convection enhanced delivery of chemotherapeutic drugs into brain tumour.
Topics: Antineoplastic Agents; Brain Neoplasms; Carmustine; Cisplatin; Computer Simulation; Convection; Doxorubicin; Drug Delivery Systems; Fluorouracil; Humans; Methotrexate; Models, Theoretical; Paclitaxel | 2018 |
Effect of tissue permeability and drug diffusion anisotropy on convection-enhanced delivery.
Topics: Anisotropy; Blood Flow Velocity; Blood-Brain Barrier; Carmustine; Cisplatin; Convection; Diffusion; Doxorubicin; Drug Delivery Systems; Extracellular Fluid; Fluorouracil; Methotrexate; Models, Theoretical; Paclitaxel; Permeability; Pharmaceutical Preparations; Pressure; Spatial Analysis | 2019 |
Convection enhanced delivery of anti-angiogenic and cytotoxic agents in combination therapy against brain tumour.
Topics: Angiogenesis Inhibitors; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Brain Neoplasms; Carmustine; Cisplatin; Convection; Cytotoxins; Doxorubicin; Fluorouracil; Humans; Methotrexate; Microvessels; Models, Biological; Paclitaxel | 2020 |
Diagnostic delay and outcome in immunocompetent patients with primary central nervous system lymphoma in Spain: a multicentric study.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Central Nervous System Neoplasms; Chemoradiotherapy; Cranial Irradiation; Cytarabine; Delayed Diagnosis; Female; Follow-Up Studies; Humans; Immunocompetence; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prognosis; Retrospective Studies; Survival Rate; Young Adult | 2020 |
R-CHOP intensification with mid-cycle methotrexate and consolidating AraC/TT with BCNU/aHSCT in primary aggressive lymphoma with CNS involvement.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Central Nervous System Neoplasms; Cyclophosphamide; Cytarabine; Doxorubicin; Female; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Middle Aged; Prednisone; Progression-Free Survival; Retrospective Studies; Rituximab; Vincristine | 2022 |
Improved survival outcomes despite older age at diagnosis: an era-by-era analysis of patients with primary central nervous system lymphoma treated at a single referral centre in the United Kingdom.
Topics: Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Central Nervous System Neoplasms; Cyclophosphamide; Cytarabine; Dexamethasone; Doxorubicin; Drug Administration Schedule; Female; Hematopoietic Stem Cell Transplantation; Hospitals, University; Humans; Kaplan-Meier Estimate; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Mortality; Progression-Free Survival; Proportional Hazards Models; Retrospective Studies; Transplantation, Autologous; Treatment Outcome; United Kingdom; Vincristine | 2021 |
Rituximab, Methotrexate, Carmustine, Etoposide, and Prednisone (RMBVP) for the treatment of relapsed/refractory primary central nervous system lymphoma: a retrospective single-center study.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Central Nervous System; Central Nervous System Neoplasms; Etoposide; Female; Humans; Lymphoma, Non-Hodgkin; Methotrexate; Neoplasm Recurrence, Local; Prednisone; Retrospective Studies; Rituximab | 2022 |
High-dose chemotherapy and autologous stem cell transplantation in primary lymphomatoid granulomatosis of the central nervous system.
Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Central Nervous System Viral Diseases; Cytarabine; Epstein-Barr Virus Infections; Female; Humans; Lymphomatoid Granulomatosis; Male; Methotrexate; Middle Aged; Peripheral Blood Stem Cell Transplantation; Rituximab; Thiotepa; Transplantation, Autologous; Treatment Outcome | 2023 |